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Introduction and aim of the thesis. 
Chapter I 
Introduction and aim of the thesis. 
Chapter I 
Epidemiology/15) 
Gastrointestinal tumours are among the most common malignancies in Western popula-
tions. Despite recent advances in diagnosis and therapy they still have high mortality and 
low survival rates. Marked international differences in incidence rates and migrant studies 
suggest that life-style factors and more in particular dietary habits may play an important 
role in the etiology of these cancers. Case-control and cohort studies on the possible 
protective effect of the consumption of vegetables and fruits have shown that consumption 
of high levels of vegetables and fruits is consistently associated with a reduced risk of 
cancer at most sites. The association is most marked for epithelial cancers, particularly 
those of the alimentary tract. 
Anticarcinogens/6"11J 
Vegetables and fruit contain a large number of chemical compounds including major 
nutrients such as protein, fat and carbohydrates as well as minor constituents. Some of 
these minor constituents are nutrients, e g. vitamins and minerals, but most are without 
apparent nutritional value. However, it is becoming clear that some of these compounds 
may have rather profound effects in cancer prevention. Information pertaining to the 
anticarcinogenic potential of these minor non-nutritive constituents comes from three 
levels. The first are studies in which responses in animal carcinogenicity bioassays 
(Figure 1.) have been compared between experimental animals fed diets composed of 
natural components and diets composed almost entirely of purified materials (semipunfied 
diets). A higher tumour incidence was found in animals fed the semipunfied diets which 
were almost completely lacking non-nutritive constituents. The second and third level of 
information comes from studies on single crude dietary components such as cruciferous 
vegetables, citrus fruits and garlic, and from studies on specific non-nutritive substances 
of vegetables and fruits such as glucosinolates, flavonoids, phenolic acids and 
organosulfides. An impressive and still growing number of non-nutritive constituents of 
vegetables and fruits have been shown to inhibit chemically induced carcinogenesis in 
several animal carcinogenicity models (Table 1). These chemopreventive agents are called 
anticarcinogens and can be mainly classified according to the time in the carcinogenic 
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Figure J Simplified scheme for testing anticarcinogenic compounds 
animals 
control group experimental group 
I 
tumour inducing agent 
standard diet anticarcinogenic diet 
tumour incidence rate 
process, ι e initiation, promotion, conversion and progression, at which they are 
effective Some anticarcinogens act as blocking agents by preventing carcinogens from 
reaching or reacting with critical target sites, while others act as suppressing agents by 
preventing the transformation of initiated cells into tumours The insight into the modes of 
action of most anticarcinogens is still very limited and a classification based upon their 
mechanisms is not yet possible There are indications that they may be effective by virtue 
of modulating activity or composition ot detoxification systems, e g glutathione S-
transferases Such changes in biotransformation may play a key role in the altered suscep­
tibility to carcinogens we are exposed to daily, and thus may influence the risk for 
developing cancer 
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Table 1 Some examples showing the chemopreventive potential of dietary anticarcmogens 
Anticarcinogen Species Tumour inducing Target organ Decrease in 
agent(s) tumour yield 
Brussels sprouts 
Garlic oil 
Lemon oil 
Phenethyhsothiocyanate 
Diallylsulfide 
Oltipraz 
Quercetin 
rat 
mouse 
mouse 
rat 
rat 
rat 
mouse 
DMBA 
DMBA/TPA 
MNPB 
NBMA 
NMBA 
AOM 
AOM 
breast 
skin 
forestomach 
esophagus 
esophagus 
colon 
colon 
40% 
80% 
100% 
99% 
100% 
30% 
75% 
Abbreviations DMBA 7,12-dimethylbenz(a)anthracene TPA tetradecanoylphorbolacetate MNPB 
4 (methylmtrosamine)-l (3 pyndyl) l-butanone NBMA N mtrosobenzylmethylamine NMBA N-
nitrosomethylbenzyamme AOM azoxymethane 
Glutathione S-transferases.(12 1 6 ) 
The glutathione S-transferases (EC 2 5 118) constitute a complex supergene family 
of enzymes that collectively metabolize a broad spectrum of harmful compounds, 
including many (pre)carcinogens such as aflatoxin Bl-8,9-oxide, l-nitropyrene-4,5-oxide 
and benzo(a)pyrene 7,8-diol 9 10 oxide, by catalyzing their conjugation to glutathione As 
a result biological activity and excretabihty of the conjugate compared to the parent 
compound generally are decreased and increased respectively Mammalian glutathione S-
transferase isozymes, which are mainly present in the cytosol, have been grouped based 
upon catalytic properties, immunochemical cross reactivities and N terminal amino acid 
sequences into four classes, namely α, μ, π and θ (Table 2) Glutathione S transferase 
isozymes demonstrate tissue-specific expression (Table 3) and substrate selectivity 
Because these enzymes form an important detoxification mechanism variations in their 
expression levels either by genetic or external factors can have profound effects on 
susceptibility to cellular damage by toxicants 
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Table 2 Classification of cytosoltc glutathione S-transferase subumts from rat and man 
Species Class 
Rat Ya(l) Ybl (3) Yf or Yp (7) Yrs 
Man Al Mia PI Tl 
T2 
Yc(2) 
Yk 
 
A2 
Yb2 (4) 
Yn 
Yo 
 
Mlb 
M2 
M3 
M4 
M5 
 
Table 3. Tissue-specific distribution of rat glutathione S-transferases. 
Tissue Class 
α μ •к 
Intestine + + + 
Liver + + 
Kidney + - + 
Heart - + + 
Erythrocytes + 
+ = present in considerable amounts, - = not detectable or present in traces 
Aim of the thesis. 
The aim of the investigations, presented in this thesis, was to study the relationship 
between dietary anticarcinogens and gastrointestinal glutathione S-transferase activity and 
isozyme composition. Knowledge of the mode of action of anticarcinogens present in food 
may be important for cancer prevention, since research could then be focused on finding 
the most potent chemopreventive substances. 
5 
Chapter I 
Reviews used and recommended. 
1 Rogers AE and Longnecker MP (1988) Biology of Disease Dietary and Nutritional 
influences on cancer a review of epidemiologic and experimental data Laboratory Investi­
gation, 59, 729-759 
2 Willet WC (1991) Diet and human cancer In Brugge J, Curran Τ, Harlow E and 
McCormick F (eds ) Origins of human cancer A comprehensive review Cold Spring Harbor 
Laboratory Press, NY, pp 191-198 
3 Steinmetz KA and Potter JD (1991) Vegetables, fruit, and cancer I Epidemiology Cancer 
Causes and Control, 2, 325-357 
4 Block G, Patterson В and Subar A (1992) Fruit, vegetables and cancer prevention a review 
of the epidemiological evidence Nutrition and cancer, 1-29 
5 Miller AB, Bernno F, Hill M, Pietinen P, Riboh E and Wahrendorf J (1994) Diet in the 
aetiology of cancer a review European Journal of Cancer, 30, 207-220 
6 Carr BI (1985) Chemical carcinogens and inhibitors of carcinogenesis in the human diet 
Cancer, 55, 218-224 
7 Fiala ES, Reddy BS and Weisburger JH (1985) Naturally occurring anticarcmogenic 
substances in foodstuffs Annual Reviews in Nutrition, 5, 295-321 
8 Steinmetz KA and Potter JD (1991) Vegetables, fruit, and cancer II Mechanisms Cancer 
Causes and Control, 2, 427-442 
9 Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary constituents Cancer 
Research, 52, 2085-2091 
10 Morse MA and Stoner GD (1993) Cancer chemoprevention principles and prospects 
Carcinogenesis, 14, 1737-1746 
11 Dragsted LO, Strube M and Larsen JC (1993) Cancer-protective factors in fruits and 
vegetables biochemical and biological background Pharmacological Toxicology, 72, 1 Ιο­
ί 35 
12 Mannervik В (1985) The isoenzymes of glutathione transferase In Meister A (ed ) Advances 
in enzymology J Wiley and Sons, NY, Vol 57, pp 357-406 
13 Pickett CB and Lu AYH (1989) Glutathione S-transferases gene structure, regulation, and 
biological function Annual Reviews in Biochemistry, 58, 743-64 
14 Vos RME and Van Bladeren PJ (1990) Glutathione S-transferases in relation to their role in 
the biotransformation of xenobiotics Chemico-Biological Interactions, 75, 241-265 
15 Coles В and Ketterer В (1990) The role of glutathione and glutathione transferases in 
chemical carcinogenesis Critical Reviews in Biochemistry and Moleculair Biology, 25, 47-
70 
16 Beckett GJ and Hayes JD (1993) Glutathione S-transferases biomedical applications 
Advances in Clinical Chemistry, 30, 281-389 
6 
Biochemical Pharmacology (1992), 44, 596-600. 
Chapter II 
Induction of rat hepatic and intestinal glutathione S-
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Chapter II 
Abstract. 
To obtain insight into the protection mechanism of butylated hydroxyanisole (BHA), a 
widely used food preservative with anticarcinogenic properties, we investigated the effects 
of dietary BHA on rat hepatic and intestinal glutathione S-transferase (GST) enzyme 
activity, and glutathione S-transferase isozyme levels In the proximal small intestine and 
liver, BHA-supplementation significantly increased GST enzyme activity as compared to 
controls (2.3- and 1.7-fold, respectively, both Ρ<0.05) GST class-α and -μ contents 
were significantly higher only in the small intestine (1.6-2.1-fold and 1.3-1.5-fold, 
respectively, P<0.05), whereas GST class-π was significantly induced in liver (4.6-fold, 
P<0.05). 
Introduction. 
Humans are exposed daily to complex mixtures of chemical compounds in their food 
(1). An important portal of entry for these compounds is the gastrointestinal tract (1,2). In 
this case the intestinal mucosa is the first-line barrier. The capability of mucosal cells to 
detoxify these substances is essential for a good protection against these xenobiotics. The 
detoxification or biotransformation is the total of biochemical reactions which results in 
the modification and excretion of the exogenous molecules. Important biotransformation 
enzymes are glutathione S-transferases (GSTs), consisting of a family of isoenzymes with 
partly overlapping substrate specificities (3,4) Therefore, not only the total enzyme 
activity but also the levels of the different isoenzymes may determine the risk for 
damaging effects or even the development of cancer (5,6). 
Colon cancer is a major health problem in Western society. It is the second most 
frequent malignancy and the incidence is still increasing. Epidemiological studies showed 
that environmental factors, such as dietary habits, may play a role in colon carcinogenesis 
(7). However, food also contains compounds which are considered to be anticarcinogenic 
(7-9). Butylated hydroxyanisole (BHA) is a widely used food preservative with anticar­
cinogenic properties (10-12) A possible mechanism of the chemopreventive action of 
BHA may be the induction of detoxification enzymes resulting in lower levels of reactive 
electrophilic metabolites of many xenobiotics (13-17) Knowledge about the exact 
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protection mechanisms of anticarcinogenic compounds present in food may be of impor-
tance for the reduction or prevention of colon cancer. This paper reveals induction of 
GSTs in the liver and intestine by BHA as a possible anticarcinogenic mechanism. 
Materials & Methods. 
Treatment of animals. Male Wistar rats (200 + 10 g), were obtained from the Central 
Laboratory Animal Center (University of Nijmegen, the Netherlands). The animals were 
housed individually on wooden shavings in macrolon cages maintained at 20-25°C and 
30-60% relative humidity. A ventilation rate of seven air changes/hr and a 12 hr 
light/dark cycle was used 
The rats were randomly assigned into two groups (nine animals each). Both groups 
were fed powdered RMH-TM lab chow (Hope Farms, Woerden, The Netherlands). After 
acclimatization for 3 days, the animals were fed either the basal diet (RMH-TM) or the 
experimental diet, which was prepared by supplementation with 2(3)-iert-butyl-4-
hydroxyanisole (BHA) at a concentration of 1% (w/w). A food processor was used to 
obtain a homogeneous mixture of BHA and the powdered lab chow. Body weight was 
recorded daily and freshly prepared food was given every 2-3 days During the ex-
periment, the rats had free access to the diets and tap water. After 2 weeks the animals 
were killed by decapitation. 
Tissue preparation. The intestine and liver were immediately excised and the intestine 
was dissected in four segments· proximal, middle and distal small intestine, and large 
intestine. Each segment was slit longitudinally and the contents were removed by washing 
with chilled buffer A (0.25 M saccharose, 20 mM Tris, 1 mM dithiothreitol, pH 7.4). 
The organs were frozen in liquid nitrogen and stored at -80°C. For preparation of the 
cytosolic fraction, the tissue was thawed quickly using cold running water. The mucosal 
surface of the intestinal segments was collected by scraping with a scalpel and the 
mucosal scrapings were homogenized in buffer A (4 ml/g tissue) in a glass/glass Potter-
Elvehjem tube. The liver was also homogenized in buffer A (4 ml/g tissue) with 10 
strokes at 1000 rpm of a motor-driven Potter-Elvehjem Teflon Homogenizer (Braun, Ger-
many). The homogenate was centrifuged at 9,000 g (4°C) for 20 minutes The resulting 
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supernatant fraction was transferred to an ultracentnfuge tube and spun at 150,000 g 
(4°C) for 50 minutes. Aliquots of the 150,000 g supernatant, representing the cytosohc 
fraction, were frozen in liquid nitrogen and stored at -80CC until use. All aforementioned 
handlings were performed on ice 
Assays. Protein was assayed in duplicate by the method of Lowry et al (18) using 
bovine serum albumin as the standard. GST activity with l-chloro-2,4-dinitrobenzene as 
substrate was determined according to Habig et al. (19). Cytosolic GST samples were 
subjected to SDS-PAGE (11% w/v acrylamide) according to Laemmli (20), and subse­
quently, western blotting Western blotting was performed as described before (21), using 
a semi-dry blotting system (Novablot II, Pharmacia, Upsala, Sweden) The western blots 
were treated with monoclonal antibodies against human GST class-α (22), -π (23) and -μ 
(24). Class-α antibodies react with rat GST subunit 1, class-π with rat GST subunit 7 and 
class-μ with rat GST subunits 3 and 4. The specific binding of the monoclonal antibodies 
to their antigens was detected with 4-chloro-l-naphthol after incubation with peroxidase-
conjugated rabbit anti-mouse second antibody (Dakopatts, Glostrup, Denmark) Staining 
on the immunoblots was quantified by densitometnc analysis, using a laser densitometer 
(Ultrascan XL, LKB, Bromma, Sweden) Known amounts of purified GST-a,-7r and -μ 
were run in parallel with the experimental samples and served as standards for the cal­
culation of the absolute amounts of these enzymes. 
Materials. BHA, dithiothreitol, glutathione, CDNB and bovine serum albumin were 
purchased from the Sigma Chemical Co (St Louis, MO, U.S.A ). 
Statistical analysis. Wilcoxon rank-sum test was used to assess statistical significance 
of differences between experimental and control groups; Ρ< 0.05 is considered as signifi­
cantly different 
Results. 
At termination of the experiment, a significantly lower gain in body weight for the 
BHA group (mean + SEM, 34.5 + 3 4 g, P<0.05) versus the control group (74 ± 2.8 
g) was noted. The average daily consumption of BHA was about 0 5-1 g/kg body weight. 
Table 1 shows the effects of dietary BHA on the specific activity of GST in the different 
10 
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parts of the intestine and in the liver. The most profound changes in GST activity were 
observed in the liver and proximal small intestine where the observed values were 
significantly higher in the treated animals. Longitudinal distribution of the GST activities 
measured showed a decline in activity going from proximal to the distal small intestine, 
with a rise in the large intestine. 
Table 1 GST activity in hepatic and intestinal cytosols of control and BHA-supplemented Wistar 
rats. 
GST activity (nmol/min mg protein) 
Small intestine Large Liver 
intestine 
Proximal Middle Distal 
Control 2 9 8 + 1 6 137 + 9 44 ± 4 74 ± 5 1592 ± 57 
BHA 679 + 53* 198 ± 2 0 53 + 3 80 ± 5 2702 + 159* 
GST activity was assayed as described in Materials & Methods Values given are means ± SEM 
for nine animals in each group, with three measurements per rat. Wilcoxon rank-sum test, 
Ρ<0.05, BHA-supplemented versus control. 
GST subclasses were quantified by densitometric analysis of western blots, after 
immunodetection with specific monoclonal antibodies against class-α, -x and -μ GST. 
Results are presented in Table 2 and Fig. 1. GST-α was expressed in the small intestine 
and liver in considerable amounts, but was hardly detectable in the large intestine. In 
contrast, GST-7T was most profoundly expressed in the large intestine, but was hardly 
detectable in liver (Fig 1). BHA-supplementation results in an increase in all classes of 
GST. In the small intestine GST-α and -μ were significantly induced, whereas in the liver 
GST-τ was significantly induced. In the large intestine none of the three classes was 
induced (Table 2.) 
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Table 2 Hepatic and intestinal class-α, -μ and -π GSTs in control and BHA-supplemented Wistar 
rats 
GST content (ng/mg protein) 
Small intestine Large Liver 
Proximal Middle Distal intestine 
GST-α Control 4130 + 630 2430 ± 360 6 5 0 + 1 3 0 70 ± 30 11580+1610 
BHA 6810 + 690* 4110 + 680* 1370 + 400* 60 + 20 16120 ± 2260 
GST-μ Control 4070 ± 480 3230 ± 3 1 0 2590 + 250 3860 + 440 47530 ± 2530 
BHA 6220 + 500* 3970 + 390 3450 + 310* 4990 ± 640 54890 ± 4220 
GST-7T Control 631 + 9 5 397 + 90 168 ± 46 1397 + 217 90 ± 58 
BHA 777 ± 81 557 ± 127 266 ± 93 1477 ± 2 6 4 416 ± 146* 
GST content was determined as described in Materials & Methods Values given are means ± 
SEM for eight animals in each group Wilcoxon rank-sum test P<0 05, BHA-supplemented 
versus control 
12 
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m pr mi di co m M m 
Fig.l. Effects of dietary BHA on rat hepatic and intestinal class-α, -π and -μ GSTs. The 
expression levels of the three classes of GST in different parts of the intestine and liver from 
Wistar rats were examined. Hepatic and intestinal 150,000 g supernatant fractions were isolated, 
and subjected to SDS-PAGE and western blotting as described in Materials & Methods. Western 
blots were treated with monoclonal antibodies against class-ct (panel A), class-τ (panel B) and 
class-μ (panel C) GST. Pr, Mi and Di, proximal, middle and distal small intestine, respectively; 
Co, colon plus coecum; Li, liver. Purified GSTs serve as marker (M). Each lane consists of 
cytosolic protein from a control (first) and a BHA-treated animal (second). Panel A: Pr, Mi and 
Di 20 ßg; Co 40 μg; Li 2.5 μg and purified GST-a from human liver 62 ng. Panel B: Pr, Mi, Di 
and Co 80 μg; Li 40 μg and purified GST-ж from human placenta 100 ng. Panel C: Pr, Mi, Di 
and Co 10 μg; Li 2.5 μg and purified GST^from human liver 137 ng. 
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Discussion. 
Dietary administration of the antioxidant BHA has been shown to decrease the inci-
dence of carcinogen-induced neoplasia in rodents (25) Biochemical investigations have 
revealed that BHA has a profound effect on several hepatic and extrahepatic enzyme 
activities such as GSTs (17,26-29) In addition, GSTs have been shown to protect against 
the damaging of DNA by metabolites of polycyclic hydrocarbons or aflatoxin Bl, both by 
catalysing the conjugation of reactive metabolites with glutathione and by covalent binding 
of reactive species (11,12) Thus, it is suggested that the concentration of reactive 
metabolites of drugs, plant toxins and environmental pollutants will decrease more rapidly 
when GST levels are higher Although the protection mechanism(s) of BHA against colon 
carcinogenesis has been studied extensively, little is known about the effects of BHA on 
GST enzyme activity at the level of the target organ the colon Furthermore, it is well 
established that GST is a family ot isozymes that have different but overlapping substrate 
specificities and are under regulation of different genes (3) To understand the mechan-
isms of modulation of drug metabolism by dietary factors such as BHA, it is important to 
study the effects not only on the total enzyme activity, but also to notify the changes in 
isozyme levels that may occur 
In a previous study by Brouard et al (30), it was shown that a lower food intake had 
no influence on the mducibihty of drug-metabolizing enzymes Thus, the observed lower 
gain in body weight for the BHA group as compared with the controls may not influence 
the effects of BHA on GST Dietary BHA has been shown to increase hepatic GST 
activity in rodents (27,31-33) Some studies showed an increase in GST activity in the 
(proximal) small intestine (27,29,32,33) However, much less is known about the effects 
in the colon De Long et al (27) found no differences in GST activity towards CDNB in 
the colon between BHA-treated mice and controls Jaeschke and Wendel (32) studied the 
effects of BHA 1 g/kg/day for 5 days on mouse colon and found also no induction of 
GST enzyme activity However, in another study by the same authors (33) mice were 
treated for 14 days with the same dose and a significant induction (P<0 01) in the colon 
was seen In our study on BHA-treated rats GST activity was significantly increased only 
in the proximal small intestine and liver This might be explained by absorption ot BHA 
14 
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mainly in the proximal small intestine As a consequence, only minor amounts of BHA 
may reach the lower part of the intestine Nevertheless, the load of toxic or carcinogenic 
compounds in the colon may be reduced by a more efficient detoxification, due to 
increased levels of GSTs in the proximal intestine Therefore, one may speculate that 
BHA can protect against colon carcinogenesis, although no dramatic increase in GSTs 
was achieved in the colon itself 
Pearson et al (34) studied GST induction by BHA at the level oí mRNAs Den-
sitometncal analysis of autoradiographs showed an induction in the liver and intestine of 
BHA treated mice Class-μ and -a GST mRNA levels increased 15- and 50-fold, 
respectively, in the liver, and 15- and 100-fold, respectively, in intestinal mucosa in 
response to BHA treatment Class-7r mRNAs were much less responsive to BHA 
treatment Studying GST induction at the enzyme (protein) level, we find much lower 
responses (0 9-2 1-fold), with a 4 6-fold induction of GST τ in the liver This indicates 
that changes at the mRNA level are of another order of magnitude as compared with the 
changes at the enzyme level This observation is supported by the data on GST enzyme 
activity (1 1 2 3-fold induction, see Table 1) and by the studies of Benson et al (35), 
McLellan and Hayes (36) and Hayes et al (37) who showed that GST isozyme contents 
in the livers of mice were affected by dietary BHA in a way similar to that described 
here In addition to the studies on GST induction by BHA, we also investigated the 
isozyme patterns at different locations in the intestine As shown in Table 2, statistically 
significant differences were observed in the small intestine for class-α and -μ GSTs, and 
in the liver for GST-π 
The present study demonstrates that a marked induction of hepatic and intestinal GSTs 
occurs in BHA-fed rats The ability of dietary BHA to attenuate the carcinogenic effects 
of certain xenobiotics may be the result of an accelerated elimination of these compounds 
due to this induction of GSTs It should be stated that the dose used in our study seems to 
be of minor relevance to the human situation, especially since the FAO/WHO Joint 
Expert Committee on Food Additives established an acceptable daily intake of BHA of 
0 5 mg/kg body weight (38) However, a significant hepatic GST induction occurs in 
mice at a dose of 10 mg BHA/kg body weight/day (33) which suggest that some effect on 
15 
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GSTs may be achieved in humans consuming much lower levels of BHA than those used 
in our study 
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Abstract. 
Effects of dietary naturally occurring anticarcinogens, quercetin, flavone, ellagic acid, 
feruhc acid, tannic acid, curcumin, coumann, α angelicalactone, fumane acid and 
Brussels sprouts on male Wistar rat hepatic and intestinal (ι) glutathione S-transferases 
(GST) enzyme activity, (u) GST isozyme levels and (ui) glutathione (GSH) content were 
investigated GST enzyme activity was significantly increased by all anticarcinogens 
tested, except fumane acid, at least at one of the five sites investigated proximal, middle, 
distal small intestine, large intestine and liver Only a-angelicalactone gave an enhanced 
GST enzyme activity at all five sites Large intestinal GST enzyme activity was increased 
only by quercetin (175%) and a-angelicalactone (138%) Concomitant changes in GST 
isozyme levels occurred Class-α GSTs were induced in 50% of the cases, especially in 
liver and upper parts of the intestine by quercetin, flavone, coumann and α angelicalac­
tone GST class π levels were enhanced only at one site by quercetin, coumann and a-an-
gehcalactone GST class-μ changed m 14% of the cases, most profoundly in proximal and 
middle small intestine by flavone, coumann and a-angelicalactone Tannic acid and 
fumane acid gave a significant raise in class-α GSTs at almost all sites, whereas overall 
GST enzyme activity hardly changed GSH was increased at various sites in 14% of the 
cases by Brussels sprouts, quercetin, flavone and α-angelicalactone These data 
demonstrate that most anticarcinogens, in particular flavone, coumann and a-angelicalac-
tone, enhance GST activity in liver and intestine, mainly by induction of class α and -μ 
isozymes 
Introduction 
Colon cancer is among the most common malignancies in Western society (13) It is 
distinguished by the refractory response to most conventional modes of therapy For this 
reason, research on the prevention of colon cancer is of the utmost importance (4) 
Epidemiological studies on colon carcinogenesis show the importance of environmental 
factors such as dietary habits Diets rich in yellow-green vegetables and fruit are 
associated with a lower risk (2,5-7) In the face of these epidemiologic associations many 
dietary non-nutritive constituents with anticarcinogenic properties have been identified 
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(6,8-12). A possible mechanism of the chemopreventive action of these compounds may 
be the induction of detoxication enzymes (4,8,10-16). Important drug-metabolizing or 
detoxication enzymes are glutathione S-transferases (GSTs; E C . 2.5.1.18), a family of 
enzymes divided into three main classes: α, μ and τ Each class consists of several 
isozymes with only partly overlapping substrate specificities (17-20). GSTs catalyze the 
reaction of a wide variety of electrophiles to glutathione (GSH). Since most of the 
reactive ultimate carcinogenic forms of chemical carcinogens are electrophiles, GSTs take 
on considerable importance in carcinogen inactivation (21,22). Enhancement of the 
activity of such enzyme system potentially could increase the capacity to withstand the 
burden of toxicants and (pre)carcinogens we are exposed to daily (23) Furthermore, a 
change in GST isozyme profile, even without alteration in overall enzyme activity, may 
result in a different risk on DNA damage due to substrate specifities (17,20,24). 
Knowledge of the exact protection mechanisms of anticarcinogenic compounds present in 
food may be of importance for the reduction or even prevention of colon cancer. For this 
reason, we investigated the effects of the naturally occurring dietary anticarcinogens; 
quercetin, flavone, ellagic acid, ferulic acid, tannic acid, curcumin, coumarin, a-
angehcalactone, fumarie acid and Brussels sprouts, on rat hepatic and intestinal (i) GST 
enzyme activity, (ii) GST isozyme levels and (in) GSH content. 
Materials & Methods 
Treatment of animals. Male Wistar rats (200 ± 10 g), were obtained from the Central 
Laboratory Animal Center (University of Nijmegen, The Netherlands). The animals were 
housed individually on wooden shavings in macrolon cages maintained at 20-25CC and 
30-60% relative humidity A ventilation rate of seven air changes/hr and a 12 hr 
light/dark cycle were used. The rats were randomly assigned to one of the eleven dietary 
treatment groups All groups were fed powdered RMH-TM lab chow (Hope Farms, 
Woerden, The Netherlands) After acclimatization for three days, the animals were fed 
either the basal diet or one of the experimental diets. Animals were allowed free access 
to food and water, and food cups were replenished with freshly prepared diet every 2-3 
days Food consumption and gain in body weight was recorded daily After two weeks 
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the animals were killed by decapitation 
Diets All compounds used, were shown to inhibit mutagenesis and/or (gastrointestinal) 
carcinogenesis in a number of studies by others (Table I) Anticarcinogenic properties of 
Brussels sprouts and fumane acid were reported in several studies (25,26,40-42), while 
effects on GST or NAD(P)H quinone reductase enzyme activity were only observed for 
Brussels sprouts (13,26,43-50) For this reason, we included Brussels sprouts and fumane 
acid in our study as a positive and negative control concerning GST enzyme activity, 
respectively Brussels sprouts (Brassica oleraceaé) was machine-chopped in a blender, 
incubated at 40°C for 4 hrs to enhance degradation in the plant tissue, and subsequently 
freeze-dned Brussels sprouts were incorporated at the level ot 20% (w/w) in the basal 
diet Quercetin, ellagic acid, ferulic acid, tannic acid, curcumin and fumane acid were 
incorporated at 1% (w/w) Flavone and a-angelicalactone were provided at the level of 
0 5% (w/w) and coumann at the level of 0 25% (w/w) A food processor was used to 
obtain a homogeneous mixture of test compound and basal diet (51) The dose levels used 
in this study were based upon data by other investigators (Table I) 
Tissue preparation and assays Tissue handling, isolation of intestinal mucosa and 
preparation of 150,000 g supernatants, representing the cytosolic fractions, were per-
formed as described previously (51) Protein concentration was assayed in duplicate by 
the method of Lowry et al (52) using bovine serum albumin as the standard GST 
activity with l-chloro-2,4-dinitrobenzene (CDNB) as substrate was determined according 
to Habig et al (53) Cytosolic GST samples were subjected lo sodium dodecyl sulfate -
polyacrylamide gel electrophoresis (11% acrylamide, w/v) and, subsequently, western 
blotting (51) The western blots were incubated with monoclonal antibodies against human 
GST class-α (54), -μ (55) and -ж (56) Class-α antibodies react with rat GST subunit 1, 
class-π with rat GST subunit 7 and class μ with rat GST subunits 3 and 4 The specific 
binding of the monoclonal antibodies was detected with 4 chloro-1-naphthol after 
incubation with peroxidase-conjugated rabbit anti-mouse second antibody (Dakopatts, 
Glostrup, Denmark) Staining on the immunoblots was quantified using a laser den­
sitometer (Ultrascan, LKB, Bromma, Sweden) Known amounts of purified GST-α, -ir 
and -μ were run in parallel with the experimental samples and served as standards for the 
calculation of the absolute amounts ot these enzymes (51) 
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Glutathione was quantified on HPLC (high performance liquid chromatography) after 
reaction with monobromobimane using the method of Fahey and Newton (57) with minor 
modifications In short, separations were earned out on a HPLC apparatus with a High 
Precision Pump model 480 equipped with an autosampler model Marathon and a 
spectrofluorometnc detector model Jasco 821-FP (all from Separations, The Netherlands) 
A 200x3 mm Chromsep HPLC column with a Chromspher 5C18 cartridge (Chrompack, 
The Netherlands) were used Glutathione stock solutions with high concentration (50 μΜ) 
and low pH (1% v/v acetic acid) were prepared in order to minimize loss due to 
oxidation This stock solution was further diluted to a standard curve using 10% v/v 
trichloroacetic acid The experimental samples (cytosohc fractions) were diluted with 10% 
v/v trichloroacetic acid, and centnfuged 2 min in an Eppendorf microcentrifuge in order 
to remove denaturated protein The clear supernatant was used in the assay Assay, 33 μΐ 
sample, 167 μΐ sodium borohydnde solution (2 5 mg/ml in 100 mM 4-ethyl-morpholine, 
pH = 8), 100 μΐ monobromobimane solution (2 mM in acetonitnl) After 30 mm the 
reaction was ended by adding 20 μΐ 10% v/v trichloroacetic acid The elution protocol 
(28CC, flow rate 0 35 ml/min) with linear gradient was as follows 0 mm, 100% solvent 
A (10% v/v methanol, 0 25% v/v acetic acid, 10 mM tetrabutylammoniumhydrogensul-
fate, adjusted to pH 3 5 with sodium hydroxide), 0% solvent В (100% v/v methanol, 
0 25% v/v acetic acid), 20 min, 100% solvent B, 22 mm, 100% solvent A, 36 min 
reinjection 
Materials Quercetin, coumann, ferulic acid, ellagic acid, curcumin, flavone, CDNB , 
bovine serum albumin and glutathione were purchased from the Sigma Chemical Co 
(USA) Tannic acid, α-angelicalactone and fumane acid were obtained from Aldnch 
Chemie (Germany) Methanol, acetic acid, acetonitnl from Merck (Germany) 
Tetrabutylammoniumhydrogensulfate, 4-ethyl morpholine, sodium borohydnde from 
Fluka (Germany) and monobromobimane from Calbiochem Co (USA) Brussels sprouts 
were collected in local shops 
Statistical analysis Wilcoxon rank-sum test was used to assess statistical significance 
of differences between experimental and control groups 
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Results. 
The daily food consumption and anticarcinogen intake are given in Table II. At 
termination of the experiment, the daily gain in body weight for the Brussels sprouts, 
flavone, coumarin and a-angelicalactone group was significantly lower as compared with 
the control group (Table II). 
Table II. Daily food consumption, anticarcinogen intake and gain in body weight of male Wistar 
rats receiving diets supplemented with ten different naturally occurring anticarcmogens 
Treatment 
control 
(n = 9) 
Br. sprouts 
(n=3) 
fumarie acid 
(n=3) 
quercetin 
(n=6) 
flavone 
(η=6) 
coumarin 
(η = 6) 
α-angelicalactone 
(η = 6) 
ferulic acid 
(η=6) 
ellagic acid 
(η=5) 
tannic acid 
(n=3) 
curcumin 
(η=6) 
η = number of animals Values given are means ± SD. Wilcoxon rank-sum test was used to 
assess statistical significance of differences between control and treated groups aP<0.05, 
bP<0 0I, CP<0 005, dP<0.001. 
Food consumption 
(g/day) 
22 4 + 0.5 
17 5 ± l . l b 
18 7 ± 2.3b 
20.7 + 2.2 
18.2 ± 0 9d 
13.5 ± 1 9a 
16.2 ± 0 7d 
20.5 ± 1 9 
19.2 ± 4 3 
20.7 + 08 
19 4 + 24° 
Anticarcinogen intake 
(g/day kg body 
-
175 ± 1 1 
0 9 + 0.1 
10 + 0 1 
0 5 ± 0 
0 2 + 0 
0 4 + 0 
1 0 ± 0 1 
1 0 ± 0 2 
10 + 0 
10 + 0 1 
weight) 
Gain in body 
weight 
(g/day) 
4 4 + 0.5 
2 2 ± 0 2a 
3.6 ± 1.3 
4.4 ± 0.8 
0.7 + 0.2d 
1 1 + 0 8d 
2 6 + 0 5d 
4.3 + 0.7 
2 7 + 1 7 
4 1 + 0 2 
4 2 + 0 6 
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Table III Effect of feeding ten different naturally occurring anticarcinogemc compounds on 
intestinal and hepatic GST activity. 
Treatment group 
control 
(n = 9) 
Br. sprouts 
(n = 3) 
fumarie acid 
(n=3) 
quercetin 
( n = 6 ) 
flavone 
(η = 6) 
coumarin 
(η = 6) 
α-angelicalactone 
(n=6) 
ferulic acid 
(n=6) 
ellagic acid 
(n = 5) 
tannic acid 
(n = 3) 
curcumin 
(n = 6) 
Proximal 
298 
515 
± 16 
± 89a 
355 ± 25 
361 
577 
549 
872 
408 
554 
426 
455 
± 25 
± 2 1 e 
+ 67 b 
± 62 e 
± 37 
± 39 e 
± 22a 
± 4 3 b 
GST activity (nmol/min mg protein) 
Small intestine 
Middle 
137 + 9 
224 ± 29a 
172 ± 7 
180 ± 18 
221 ± 16e 
236 ± 25L 
285 ± 15e 
168 + 12 
227 ± 26 
153 ± 4 
193 ± 13 
Distal 
44 + 4 
60 ± 2 
46 + 3 
69 ± 9 
47 + 4 
7 1 + 8 
130 + 13e 
51 + 3 
62 + 7 
58 + 3 
49 ± 2 
Large 
inteslir 
74 + 
89 ± 
ie 
6 
10 
67 + 5 
130 ± 
86 + 
91 ± 
105 ± 
82 + 
89 + 
89 ± 
77 + 
15b 
4 
9 
9 b 
5 
6 
10 
3 
Liver 
1592 ± 57 
2439 ± 90 a 
1695 + 150 
1613 ± 46 
4889 + 396e 
3750 + 230e 
3158 + 346 e 
2253 ± 120e-
2163 ± 273 
1663 + 106 
1694 + 89 
GST activity was determined in triplicate as described in Materials & Methods Values given are 
means ± SEM Wilcoxon rank-sum test was used to assess statistical significance of differences 
between control and treated groups: "P<0 01, bP<0 005, CP< 0 001 
Table III shows the effects of the anticarcinogens on GST activity in the five different 
parts of the gastrointestinal tract investigated: proximal, middle, and distal small intestine, 
large intestine and liver. All compounds tested (except fumarie acid; negative control) 
increased GST activity at one or more sites. The largest inductions were seen in small 
intestine by α-angelicalactone (2.9x), in large intestine by quercetin (1 8x) and in liver by 
flavone (З.іх). Only α-angelicalactone gave an enhancement in GST enzyme activity at 
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all five sites investigated The inducing capacity of the naturally occurring dietary anticar-
cinogens declined going from proximal small intestine to colon, except for quercetin 
which showed an inverse relation 
Representative examples of three immunoblots, detecting class-α, -τ and -μ GSTs in 
controls and coumann treated animals are presented in Figure 1 As can be seen, GST-a 
was found in considerable amounts in small intestine and liver, but not in the large intes­
tine of control rats In contrast, GST-7T was most pronouncedly expressed in the large 
intestine, but not in the liver GST-μ was present in similar quantities along the intestine 
and in high amounts in the liver 
Tables IV, V and VI show the effects of anticarcinogens on the GST class-α, -τ and -μ 
isozyme levels, respectively, at the different sites of the gastrointestinal tract investigated 
GST-α was significantly increased in all dietary groups (in 25 out of 50 possibilities, 10 
diets tested, effects measured at 5 different locations) except in the rats receiving ferulic 
acid or Brussels sprouts The most pronounced changes in GST-α levels were observed 
with quercetin, flavone, coumann, α-angelicalactone and fumane acid Interestingly, in 
the tannic acid group GST-α was enhanced in the distal small intestine and colon (250 ± 
60 ng/mg), whereas GST-α was not detectable at all in large intestine of control animals 
or any other experimental group GST-π contents were influenced in four out of the ten 
experimental groups (in 4 out ot 50 possibilities) The most striking induction was seen in 
livers of rats fed coumann, here GST-тг was detectable at very high concentrations (2779 
+ 806 ng/mg), whereas GST ж was undetectable in livers of otherwise treated or control 
animals Another remarkable effect is the 45% decrease in GST-ir levels in proximal 
small intestine of rats treated with ferulic acid GST-μ levels were higher at some 
locations in four out of ten groups (in 7 out of 50 possibilities), most notably in small 
intestine and liver of flavone and coumann treated animals For GST-μ a 32% decrease 
was seen in the ellagic acid treated animals 
In table VII, the data on GSH content are given GSH levels were increased at two 
sites in animals fed diets supplemented with Brussels sprouts, flavone and a-angelicalac-
tone, and in large intestine only in the quercetin group 
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M Pr Mi Di Co Li M 
Figure 1. Immunoblots showing the effects of dietary coumarin on rat hepatic and intestinal class-
a, -ж and -μ GSTs. Hepatic and intestinal cytosolic fractions of control and coumarin-treated 
animals were isolated, subjected to SDS-polyacrylamide gel electrophoresis and western blotting 
as described in Materials & Methods. Western blots were treated with monoclonal antibodies 
against GST class-α (Panel Α), -π (Panel B) and -μ (Panel C). M, marker; Pr, Mi and Di, 
proximal, middle and distal small intestine, respectively; Co, colon; Li, liver. Purified GSTs serve 
as markers. Each lane consists of cytosolic protein from a control (first) and a coumarin-treated 
animal (second). Panel A: Pr, Mi and Di 15 μg; Co 40 μg; Li 2.5 μg and M 155 ng purified 
GST-a from human liver. Panel B: Pr, Mi and Di 120 μg; Co and Li 80 ßg and M 200 ng 
purified GST-ir from human placenta. Panel C: Pr, Mi, Di and Co 7.5 μg; Li 2.5 pg and M 137 
ng purified GST-μ from human liver Due to small differences in molecular mass between rat and 
human (M) GST subunits the marker proteins in panels A and С have a slightly slower mobility. 
28 
International Journal of Oncology (1993), 3, 1131-1139. 
Table TV Effect of feeding ten different naturally occurring anticarcinogenic compounds on 
intestinal and hepatic GST-a levels 
Treatment group 
control 
(n = 9) 
Br sprouts 
(n=3) 
fumane acid 
(n=3) 
quercetin 
(n = 6) 
flavone 
(η = 6) 
coumarin 
(η = 6) 
α-angelicalactone 
(η=6) 
ferulic acid 
(η=6) 
ellagic acid 
(η = 5) 
tannic acid 
(n = 3) 
curcumin 
(η=6) 
Proximal 
4249 + 624 
5805 ± 816 
12420 ± 1140a 
7405 ± 516a 
10130 + 769е 
9123 ± 1266b 
10030 ± 1922a 
6716 ± 1221 
5743 ± 828 
7374 ± 957 
6278 ± 341 
GST-o 
Small intestine 
Middle 
2598 ± 368 
3167 + 456 
8892 ± 9 1 0 " 
6021 ± 803е 
7538 ± 661 е 
6764 ± 1227b 
5993 ± 639е 
4567 ± 984 
4643 ± 338b 
5530 ± 845 
4468 ± 400b 
Í level (ng/mg protein) 
Distal 
653 ± 123 
453 ± 427 
2191 ± 196a 
2849 ± 643 
2462 ± 256° 
2440 ± 485° 
2969 + 543b 
1698 ± 695 
1045 ± 154 
3670 ± 1134a 
1665 + 243b 
Large 
intestine 
N D 
N D 
N D 
N D 
N D 
N D 
N D 
N D 
N D 
Liver 
12230 ± 1567 
11250 ± 8129 
44650 ± 18931a 
25060 ± 3538b 
65090 ± 4466 е 
32880 ± 3867 е 
40420 ± 7 0 9 1 ° 
30430 ± 13995 
18110 + 3875 
250 ± 60 a 33360 + 566 a 
N D 22380 ± 4866 
GST-a levels were determined as described m Materials & Methods Values given are means + 
SEM N D = not detectable, detection limit 50 ng/mg Wilcoxon rank-sum test was used to assess 
statistical significance of differences between control and treated groups "P<0 01, bP<0 005, 
CP<0001 
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Table V. Effect of feeding ten different naturally occurring anticarcinogenic compounds on 
intestinal and hepatic GST-τ levels 
Treatment group 
control 
( n = 9 ) 
Br. sprouts 
(n=3) 
fumarie acid 
(n=3) 
quercetin 
( n = 6 ) 
flavone 
(η=6) 
coumarin 
(η=6) 
α-angelicalactone 
(η=6) 
ferulic acid 
(η=6) 
ellagic acid 
(η = 5) 
tannic acid 
(n = 3) 
curcumin 
(η=6) 
Proximal 
687 ± 84 
496 ± 197 
554 ± 86 
1157 ± 158 
480 ± 171 
907 ± 125 
828 ± 180 
376 ± 54b 
1115 ± 265 
582 + 213 
643 ± 218 
GST-
Small intestine 
Middle 
470 ± 90 
589 ± 102 
492 ± 30 
950 + 190 
344 ± 99 
724 ± 113 
775 + 196 
293 ± 90 
800 ± 201 
684 ± 391 
528 ± 122 
•x level (ng/mg protein) 
Distal 
189 ± 63 
356 ± 114 
104 ± 62 
849 ± 199 
80 ± 42 
635 ± 140 
962 ± 251 a 
119 ± 63 
407 ± 147 
569 ± 465 
223 ± 67 
Large 
intestine 
1432 ± 201 
1459 ± 248 
1555 + 215 
3507 ± 559b 
1409 ± 189 
1780 ± 292 
2452 ± 486 
1714 ± 269 
2046 ± 367 
3532 ± 1371 
2096 + 240 
Liver 
N.D 
N D. 
N.D 
N D 
N D. 
2779 ± 806 e 
N.D 
N D 
N D 
N D 
N D 
GST-тг levels were determined as described in Materials ά Methods. Values given are means ± 
SEM. N D. = not detectable, detection limit 50 ng/mg Wilcoxon rank-sum test was used to assess 
statistical significance of differences between control and treated groups aP<001, hΡ < 0.005, 
CP< 0.001 
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Table VI Effect of feeding ten different naturally occurring anticarcinogemc compounds on 
intestinal and hepatic GST-μ levels 
Treatment group 
control 
(n = 9) 
Br sprouts 
(n=3) 
fumane acid 
(n = 3) 
quercetin 
(n=6) 
flavone 
(π=6) 
coumarin 
(η=6) 
α-angelicalactone 
(η=6) 
ferulic acid 
(η = 6) 
ellagic acid 
(η = 5) 
tannic acid 
(n=3) 
curcumin 
(η=6) 
Proximal 
4018 ± 466 
6365 ± 1863 
4530 ± 215 
4995 ± 397 
7395 ± 824b 
9272 ± 1482b 
9084 ± 1373e 
4608 ± 579 
3935 ± 445 
6480 + 1203 
5304 ± 830 
GST-μ level (ng/mg protein) 
Small intestine 
Middle 
3195 ± 300 
4207 ± 938 
3708 ± 279 
3609 ± 339 
4682 ± 294a 
7099 ± 1902a 
3771 ± 214 
3301 ± 487 
2328 ± 131 
4827 ± 853 
3258 ± 417 
Distal 
2567 ± 242 
4011 ± 386 
2938 ± 274 
2647 ± 4 1 2 
3663 + 298 
4855 ± 1722 
3165 + 191 
2626 ± 586 
1711 ± 277 
5401 ± 1051 
2355 ± 562 
Large 
intestine 
3804 ± 427 
3553 ± 1 1 9 0 
2909 ± 806 
2954 ± 93 
4164 ± 783 
4539 ± 843 
2225 ± 52 
2586 ± 458 
1904 ± 378 
4994 ± 1263 
2807 ± 556 
Liver 
47130 ± 2426 
37250 ± 1 5 3 1 
57850 ± 6062 
51180 ± 1774 
67830 ± 4495 e 
73950 ± 15782 
53970 ± 2883 
41180 ± 3819 
32190 ± 3630 b 
57500 ± 732 
43290 ± 2681 
GST-μ levels were determined as described m Materials & Methods Values given are means ± 
SEM Wilcoxon rank-sum test was used to assess statistical significance of differences between 
control and treated groups aP<0 01, bP<0 005, CP<0 001 
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Table VII Effect of feeding ten different naturally occurring anticaranogemc compounds on 
intestinal and hepatic GSH levels 
GSH (nmol/mg protein) 
Treatment group Small intestine Large Liver 
Proximal Middle Distal intestine 
control 10 9 ± 17 15 1 ± 1 5 7 6 ± 1 4 2 1 5 ± 3 2 49 2 ± 4 4 
(n = 9) 
Br sprouts 313 ± 7 6 326 ± 13 a 19 0 ± 1 8a 274 + 4 9 707 + 85 
(n = 3) 
fumane acid 16 2 + 2 4 18 8 ± 1 9 6 8 ± 0 4 24 9 ± 4 2 68 1 ± 7 6 
(n=3) 
quercetin 17 4 + 5 3 19 9 ± 4 6 1 1 1 + 3 8 41 6 + 4 9b 54 7 + 4 8 
(n=6) 
flavone 21 7 + 1 2b 30 6 ± 2 6C 13 8 ± 1 6 2 0 7 + 1 9 62 3 ± 7 6 
(n=6) 
coumann 8 5 ± 2 5 12 6 ± 2 9 4 9 ± 2 1 17 2 ± 15 66 9 + 8 9 
(n=6) 
a-angelicalactone 23 1 + 5 3 25 3 ± 2 5c 15 0 + 4 3 27 4 + 3 8 79 0 + 5 Ie 
(n=6) 
feralic acid 13 6 + 2 0 15 5 + 18 5 3 + 1 3 21 7 ± 2 5 57 1 ± 8 2 
(n = 6) 
ellagic acid 16 3 + 39 18 8 + 17 4 6 + 1 2 23 0 + 2 0 77 6 ± 16 3 
(n = 5) 
tannic acid 21 5 ± 2 8 23 6 + 2 8 13 6 ± 2 1 29 2 ± 4 5 45 0 ± 16 
(n = 3) 
curcumin 8 7 + 1 6 1 3 0 + 1 0 3 9 ± 0 6 17 0 ± 2 0 3 8 5 ± 4 0 
(n=6) 
GSH levels were determined as described in Materials & Methods Values given are means ± 
SEM Wilcoxon rank-sum test was used to assess statistical sigmcance of differences between 
control and treated groups aP<0 01, bP<0 005, CP<0 001 
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Discussion. 
It is well known that environmental factors affect the development of human cancers 
Even the human diet contains a large number of (pre)carcmogens (23) However, apart 
from carcinogens our diet also contains a variety of compounds which inhibit mutagenesis 
and/or carcinogenesis in laboratory models (9,23,58) These anticarcinogens are very 
diverse in chemical structure, and their protective mechanisms are generally unclear 
However, there are some indications that anticarcinogens are effective by virtue of 
enhancing detoxication systems (8,11-14,21) These detoxication systems, such as GSTs, 
can minimize carcinogenicity by Phase II conjugation reactions, which add functional 
groups to the carcinogen, thereby lowering the biological activity and increasing its 
excretabihty Although induction of GST enzyme activity has been suggested as a protec-
tive mechanism of some dietary anticarcinogens (13), little is known about the effects of 
anticarcinogens on GST enzyme activity in the colon, the location where most gastrointes 
tmal tumours are formed To understand the modulation mechanism of drug-metabolizing 
enzymes by naturally occurring dietary anticarcinogens, it may be important due to 
substrate specificities to study changes in isozyme levels in addition to the measurement 
of enzyme activity 
In four experimental groups (Brussels sprouts, flavone, coumann and a-angelicalac-
tone) the daily gain in body weight was lower as compared with control group (Table II) 
However, Brouard et al (59), showed that a lower gain in body weight due to a restricted 
diet had no influence on the inducibihty of drug-metabolizing enzymes in liver and 
intestine Therefore, we believe that in our study a lower gain in body weight did not 
influence the effects on GST enzyme activity because all four groups also had a lower 
food consumption (Table II) 
Brussels sprouts (27,43,44,46 48), quercetin, flavone (59 61), ellagic acid (62), 
coumann and a angehcalactone (32,63) have earlier been reported to influence hepatic 
GST enzyme activity in a similar way as observed here Abovementioned six compounds, 
except ellagic acid, where shown to modulate GST enzyme activity in proximal small 
intestine (26,32,43,45,47,48,59,63) However, partly different results were obtained 
While in our study flavone significantly increased GST enzyme activity in proximal and 
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middle small intestine, Brouard et al (59) found no effect in proximal small intestine 
This discrepancy may be caused by a different dietary regimen, since Brouard et al used 
a lower dose of flavone (0 25% w/w vs 0 5% w/w), and their rats were fasted 18 hours 
before collecting tissues whereas our animals had free access to food until decapitation 
Since starvation is known to decrease GST enzyme activity (64,65) an initial small 
increase in GST enzyme activity may have vanished during the starvation period 
To our knowledge this is the first time that effects of anticarcinogens on GST enzyme 
activity in the colon are reported Colonic GST enzyme activity was significantly 
increased by quercetin (1 8x) and α-angelicalactone (1 4x), whereas GST enzyme activity 
in small intestine was increased by seven anticarcinogens Since the gastrointestinal tract 
is an important portal of entry for many toxicants and carcinogens, the intestinal mucosa 
acts as a lirst-hne barrier Due to induction of GST enzymes in the intestine a more 
efficient detoxication of carcinogenic compounds may take place, resulting in less damage 
of DNA in the epithelial cells of the colon In this way, the naturally occurring dietary 
anticarcinogens could be of significance in the prevention of gastrointestinal cancers 
Until now, little is known about the effects of naturally occurring dietary anticar­
cinogens on levels of GST isozymes Bogaards el al (47) studied the effects of Brussels 
sprouts on GST subunit levels in rat liver and small intestine A linear relationship 
between the amount of Brussels sprouts in the diet and GST subunits 1,2 and 3 levels was 
found in liver, whereas subunit 4 was not induced In contrast, in small intestinal mucosa 
subunit 4 showed the greatest effect In our study, consumption of Brussels sprouts 
resulted in an uniform increase of GST activities, whereas no dramatic changes in 
isozyme levels were observed For the other anticarcinogens studied here no data on GST 
isozyme levels have been reported before In 58% of the cases where induction of GST 
enzyme activity occured, also a significant increase in one or more classes of GST was 
observed In this group, involvement was highest tor GST class-α (91%), followed by 
GST-μ (55%) and GST-тг (27%) In addition, GST isozyme levels changed without sig­
nificant alterations in overall enzyme activity, which was found for GST class a at most 
sites after treatment with tannic or fumane acid Until now, as far as we know, no data 
on effects of anticarcinogens on GSH levels have been reported However, Sparnins et al 
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(32) showed induction of sulfhydryl levels in small intestine and esophagus by dietary 
coumann and α-angelicalactone In our study GSH, the endogenous cofactor for GST, 
was increased in 14% of all sites investigated and in 32% of the cases where GST 
enzyme activity was induced 
In conclusion, most naturally occurring dietary anticarcinogens tested, and in particular 
flavone, coumann and a-angelicalactone were able to increase GST enzyme activity, 
mainly by induction of GST a and GST μ levels, at various locations in intestine and 
liver, whereas quercetin specifically enhanced GST activity and GSH content in the large 
intestine In addition, even when enzyme activity did not change, significant variations in 
GST isozyme levels could be detected Therefore, we conclude that this increased 
detoxification capacity may account, at least in part, for the observed chemopreventive 
action of these compounds Realising that the dose of anticarcinogens given by us and in 
all other animal studies will hardly be reached in the human diet, we believe that 
modulation of activity and characteristics ot important detoxication-systems such as GST 
could still play a role in the prevention of gastrointestinal tumours 
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Chapter IV 
Quantification of induction of rat oesophageal, gastric and 
pancreatic glutathione and glutathione S-transferases by dietary 
anticarcinogens. 
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Nijmegen, The Netherlands 
Chapter IV 
Abstract. 
Four dietary naturally occurring anticarcinogens, flavone, coumann, a-angelicalactone 
and ellagic acid were studied with respect to their effects on oesophageal gastric and 
pancreatic (ι) glutathione S-transferases (GST) enzyme activity (n) GST isozyme levels 
and (in) glutathione (GSH) content in male Wistar rats GST enzyme activity was 
significantly increased in oesophagus by flavone, coumann and a angelicalactone (125%, 
240% and 155%, respectively), in stomach by coumann and a angelicalactone (140% and 
230%) No change in pancreatic GST activity was observed In addition, class- and 
tissue-specific changes in GST isozyme levels occurred Class α GSTs were induced in 
oesophagus by flavone, coumann and a angelicalactone (570%, 1580% and 570%), and 
did not change in the stomach GST-α was undetectable in pancreas GST-μ was 
expressed at high levels in all three tissues investigated, but only pancreatic GST-μ levels 
of ellagic acid fed rats were increased (160%) GST π was induced in stomach by 
coumann and α-angelicalactone (470% and 1120%), and in pancreas by flavone (200%) 
GST π was detectable at low levels in rat oesophageal epithelium of coumann fed animals 
only GSH concentrations were uninfluenced by the dietary anticarcinogens in all tissues 
These results suggest that dietary ellagic acid and more especially flavone, coumann and 
a angelicalactone may exert strong chemoprotective effects by selective enhancement of 
members of the GST detoxification system in oesophagus or stomach, and to a lesser 
extent in pancreas 
Introduction. 
Epidemiological studies have shown the importance of dietary habits in the risk for 
oesophageal, gastric and pancreatic cancer Diets rich in vegetables and fruit are 
associated with a lower risk (for review see ref 1) In the face of these epidemiologic as­
sociations many dietary nonnutritive constituents with anticarcinogenic properties have 
been identified (2-5) Though the exact mechanism(s) leading to the anticarcinogenic 
action of these compounds is not known, it has been suggested that the chemoprotective 
action may be due to elevation of detoxification enzymes (4 7) Important drug-
metabohzing or detoxification enzymes are glutathione S-transferases (GSTs, E C 2 5 1 
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18), a family of enzymes divided into three main classes α, μ and π. Each class consists 
of several isozymes with partly overlapping substrate specificities (8-10) A fourth class 
(Theta) has recently been described in man and rat liver (11) GSTs catalyze the reaction 
of a wide variety of electrophiles with glutathione (GSH) Since most of the chemical 
carcinogens are electrophiles, GSTs take on considerable importance in carcinogen 
inactivation (12,13) Enhancing the activity of the GSH/GST detoxification system 
potentially could increase the capacity to withstand the burden of toxicants and 
(pre)carcinogens we are exposed to daily (4,14) Furthermore, even a change in GST 
isozyme profile, without alteration in total enzyme activity, may result in a different risk 
on DNA damage due to the substrate specifity of the various GST isozymes (10,15,16) 
Knowledge of the protection mechamsm(s) of anticarcinogenic compounds present in food 
may be important for cancer prevention since then research could be focused on finding 
the most potent chemopreventive substances In order to understand better the 
anticarcinogenic potential of dietary flavone, coumann, α-angelicalactone and ellagic 
acid, which are constituents of normally consumed vegetables and fruits, we have 
determined their effects on rat oesophageal, gastric and pancreatic (ι) GST enzyme 
activity, (n) GST isozyme levels and (in) GSH content 
Materials & Methods 
Treatment of animals Male Wistar rats (200 ± 10 g), were obtained from the Central 
Laboratory Animal Centre (University of Nijmegen, The Netherlands) The animals were 
housed individually on wooden shavings in macrolon cages maintained at 20-25 °C and 
30-60% relative humidity A ventilation rate of seven air changes/hr and a 12-hr 
light/dark cycle were used The rats were randomly assigned to one of the treatment 
groups All groups were fed powdered RMH TM lab chow (Hope Farms, Woerden, The 
Netherlands) After acclimatization for three days, the animals were fed either the basal 
diet or one of the four experimental diets Animals were allowed free access to food and 
water, and food cups were replenished with freshly prepared diet every 2-3 days Food 
consumption and gain in body weight were recorded daily After two weeks the animals 
were killed by decapitation 
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Diets Compounds and dose levels used, were selected based on studies by others 
showing anlimutagenic and/or anticarcinogenic properties (see ref 6 for overview) Ellagic 
acid was incorporated in the diet at 1% w/w, flavone, α angelicalactone and coumann 
were provided at levels of 0 5%, 0 5% and 0 25% w/w respectively A food processor 
was used to obtain a homogeneous mixture of test compound and basal diet (17) 
Tissue preparation and assays Tissue handling, isolation of epithelium and preparation 
of 150,000 g supernatants (cytosohc fractions) were performed as described previously 
(17) In order to largely inhibit the proteolytic activity present in pancreas, a different 
homogenization buffer was used for this tissue (10 mM Hepes, 0 25 M saccharose, 118 
raM sodium chloride, 4 7 mM potassium chloride, 0 1 mM ethylene glycol-bis(ß-
aminomethyl ether) Ν,Ν,Ν',Ν'-tetracetic acid, 5 mM magnesium chloride, 5 mg/ml 
bovine serum albumin, 5 mM dithiothreitol, 0 2 mg/ml soybean trypsin inhibitor, 1 
mg/ml bacitracine, 1 mM phenylmethyl sulfonylfluonde, pH 7 4) Protein concentration 
was assayed in duplicate by the method of Lowry et al (18) using bovine serum albumin 
as the standard GST activity with l-chloro-2,4-dimtrobenzene (CDNB) as substrate was 
determined according to Habig et al (19) Cytosohc GST samples were subjected to 
sodium dodecyl sulphate-poly aery lamide gel electrophoresis (11% acrylamide w/v) and, 
subsequently to western blotting (17) The western blots were incubated with monoclonal 
antibodies against human GST class-α (20), -μ (21) and -тг (22) Class-α antibodies react 
with rat GST subunit 1, class-π antibodies with rat GST subunit 7 and class-μ antibodies 
with rat GST subunits 3 and 4 The specific binding of the monoclonal antibodies was 
detected with 4-chloro-l-naphthol after incubation with peroxidase-conjugated rabbit anti-
mouse immunoglobulins as second antibody (Dakopatts, Glostrup, Denmark) Staining on 
the immunoblots was quantified using a laser densitometer (Ultrascan, LKB, Bromma, 
Sweden) Known amounts of purified GST-α, -тг and -μ were run in parallel with the 
experimental samples and served as standards for the calculation of the absolute amounts 
of these enzymes (17) 
Glutathione was quantified by high performance liquid chromatography (HPLC) after 
reaction with monobromobimane as described previously (6) 
Materials Ellagic acid, coumann, flavone, CDNB , bovine serum albumin, 
glutathione, ethylene glycol-bis(ß-aminoethyl Ν,Ν,Ν',Ν'-tetracetic, dithiothreitol, soybean 
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trypsin inhibitor and bacitracine were purchased from the Sigma Chemical Co (USA) a-
Angelicalactone was obtained from Aldnch Chemie (Germany) Monobromobimane from 
Calbiochem Co (USA) and phenylmethyl sulfonylfluonde from Pierce (USA) All dietary 
anticarcinogens used were of the highest grade purity commercially available (a-
angehcalactone 98%, ellagic acid 95%, coumann 98% and flavone 99%) 
Statistical analysis Wilcoxon rank-sum test, with Bonferroni correction for multiple 
testing, was used to assess statistical significance of differences between experimental and 
control groups d P < 0 01 and b P < 0 005 
Results. 
Daily food consumption and anticarcinogen intake of the rats are given in Table I At 
termination of the experiment, the daily gain in body weight for the flavone and coumann 
group was significantly lower as compared with the control group (Table I) 
Table I Daily food consumption, anticarcinogen intake and gain in body weight of male Wistar 
rats receiving diets supplemented with naturally occurring anticarcinogens 
Treatment group 
control 
(n = 5) 
flavone 
(n=4) 
coumann 
(n = 5) 
a angehcalactone 
(n=5) 
ellagic acid 
(n=5) 
Food consumption 
(g/day) 
21 5 ± 1 4 
22 5 + 0 5 
20 4 ± 2 3 
182 ± 2 0 
20 9 ± 2 5 
Anticarcinogen 
(g/day kg body 
-
0 6 + 0 
0 3 + 0 
0 5 + 0 1 
1 1 + 0 1 
intake 
weight) 
Gain in body weight 
(g/day) 
5 5 + 14 
0 7 + 0 5a 
3 0 + 0 8b 
3 6 + 1 0 
4 5 + 0 3 
η = number of animals Values given are means + SD Wilcoxon rank-sum lest, treated vs 
control aP<0 01 andbP<0 005 
In control animals, mean GST activity was lowest in oesophagus (66 ± 4 nmol/min mg 
protein) and activities in pancreas and stomach were identical (Table II) Table II also 
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shows the effects of the anticarcinogens on GST activity in oesophagus, stomach and 
pancreas GST activity was significantly increased in oesophagus by flavone, coumann 
and a-angelicalactone (125%, 240% and 155%, respectively), and in stomach by 
coumann and a-angelicalactone (140% and 230%, respectively) In pancreas no change in 
GST activity was observed 
Table II Effects of dietary anticarcinogens on oesophageal, gastric and pancreatic GST activity 
Treatment group 
control 
(n=5) 
flavone 
(η=4) 
coumann 
(n=5) 
a-angelicalactone 
(n = 5) 
ellagic acid 
(n=5) 
Oesophagus 
66 ± 4 
84 ± 2a 
160 + 19b 
102 ± 8b 
75 + 10 
GST activity (nmol/min mg 
Stomach 
167 ± 2 
152 + 10 
238 ± 18b 
383 ± 28b 
187 ± 9 
protein) 
Pancreas 
167 ± 2 
173 + 6 
185 ± 12 
206 ± 11 
182 ± 9 
GST activity was determined in triplicate as described in Materials & Methods Values given are 
means ± SEM Wilcoxon rank-sum test, treated vs control "P<0 01, bP<0 005 
Tables III, IV and V show the effects of the four anticarcinogens on GST class-α, -μ 
and -τ isozyme levels, respectively In control animals, mean GST-α levels are 
undetectable in pancreas, low in oesophagus (35 ± 6 ng/mg protein) and relatively high 
in gastric tissue (1619 ± 537) Oesophageal GST-α levels were highly induced by 
flavone, coumann and a-angelicalactone (570%, 1580% and 570%, respectively) GST-a 
was not influenced in stomach, and remained undetectable in pancreas during treatment 
GST-μ was expressed at high levels m all three organs investigated but only pancreatic 
tissue of ellagic treated rats showed increased GST-μ levels (160%) Pronounced changes 
in GST-π levels were observed in stomach by α-angelicalactone and coumann (1120% 
and 470%, respectively), and to a lesser extent in pancreas by flavone (200%) 
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Table III Effects of dietary anticaranogens 
Treatment group 
control 
(n=5) 
flavone 
(n=4) 
coumann 
(n=5) 
a-angelicalactone 
(n = 5) 
ellagic acid 
(n = 5) 
Oesophagus 
35 ± 6 
200 ± 41a 
554 + 99b 
199 + 39b 
100 ± 32 
on oesophageal, gastric and pancreatic GST-a levels 
GST-α level (ng/mg protein) 
Stomach 
1619 ± 537 
888 ± 372 
1202 + 562 
1942 ± 997 
1348 ± 384 
Pancreas 
N D 
N D 
N D 
N D 
N D 
GST-a level was determined as described m Materials & Methods Values given are means ± 
SEM ND = not detectable, detection limit 50 ng/mg Wilcoxon rank-sum test, treated vs 
control "P<0 01, bP<0 005 
Table IV Effects of dietary anticaranogens on oesophageal, gastric and pancreatic GST-μ levels 
Treatment group 
control 
(n = 5) 
flavone 
(n=4) 
coumann 
(n = 5) 
a-angelicalactone 
(n=5) 
ellagic acid 
(n = 5) 
Oesophagus 
5995 + 733 
4448 ± 284 
7109 ± 445 
5145 ± 230 
4647 ± 467 
GST-μ level (ng/mg protein) 
Stomach 
7752 ± 1001 
7692 + 741 
7066 ± 627 
9640 + 1215 
7714 ± 735 
Pancreas 
1761 ± 152 
2762 ± 291 
2491 ± 287 
2173 + 184 
2824 + 107b 
GST-μ level was determined as described in Materials & Methods Values given are means ± 
SEM Wilcoxon rank-sum test, treated vs control P<0 005 
47 
Chapter IV 
Table V Effects of dietary anttcarcmogens on oesophageal, gastric and pancreatic GST-τ levels 
GST-π level (ng/mg protein) 
Treatment group 
control 
(n = 5) 
flavone 
(n=4) 
coumann 
(n=5) 
a-angelicalactone 
(n=5) 
ellagic acid 
(n=5) 
Oesophagus 
N D 
N D 
150 ± 40b 
N D 
N D 
Stomach 
174 ± 63 
437 ± 115 
819 ± 199a 
1947 + 189b 
408 ± 120 
Pancreas 
919 + 89 
1841 + 106a 
1167 ± 129 
1671 + 335 
899 ± 162 
GST-τ level was determined as described in Materials & Methods Values given are means ± 
SEM N D = not detectable, detection limit 50 ng/mg protein Wilcoxon rank-sum test, treated vs 
control aP<00I,bP<0 005 
Table VI Effects of dietary anticarcinogens on oesophageal, gastric and pancreatic GSH levels 
GSH (nmol/mg protein) 
Treatment group Oesophagus Stomach Pancreas 
control 
(n=5) 
flavone 
(η =4) 
coumann 
(η = 5) 
α angel icalactone 
(n=5) 
ellagic acid 
(n=5) 
16 + 2 
15 + 2 
23 + 4 
22 + 2 
18 ± 2 
38 + 3 
3 1 + 4 
39 + 3 
5 1 + 3 
37 + 6 
N D 
N D 
N D 
N D 
N D 
GSH level was determined as described in Materials & Methods Values given are means ± SEM 
N D = not detectable, detection limit is 0 5 nmol/mg protein Wilcoxon rank-sum test was used 
to assess statistical significance of differences between control and treated groups 
48 
Carcinogenesis (1994), 15, 1769-1772. 
A remarkable effect was seen in oesophagus of rats fed coumann, where GST-ir was 
detectable at a level of 150 ± 40 ng/mg protein, whereas GST-ir was undetectable in 
oesophagus of otherwise treated or control animals In Table VI the data on GSH content 
are given GSH levels were uninfluenced by the anticarcinogens in all tissues 
Discussion. 
It is well accepted that lifestyle factors affect the development of human cancer in 
general, and more in particular gastrointestinal tumours (1) For instance, the human diet 
contains a large number of well-known (pre)carcinogens that may be of relevance in this 
respect (14) However, apart from carcinogens our diet also contains a variety of com-
pounds that inhibit mutagenesis and/or carcinogenesis in laboratory models (23-25) These 
anticarcinogens are very diverse in chemical structure, and their protective mechamsms 
are generally unclear However, there are some indications that anticarcinogens are 
effective by virtue of enhancing detoxification systems (2,5,6) These detoxification 
systems, such as GSTs, can reduce carcinogenicity by Phase II conjugation reactions, 
which add functional groups to the carcinogen, by that lowering the biological activity 
and increasing its excretabihty (12,13) 
In the flavone and coumann groups the daily gain in body weight was lower as 
compared with controls, whereas there was a normal food consumption (Table I) In 
addition, during the course of the experiment, animals were checked by experienced 
laboratory animal scientists and a veterinarian for changes in behavioural pattern in 
general and more especially during handling of the rats but no changes were observed 
Furthermore, at the end of the experiment all organs were thoroughly inspected but no 
macroscopical changes were observed Therefore, we speculate that the lower gain in 
body weight for flavone and coumann treated rats despite a normal food intake may be 
explained by subtle adverse effects of the test compound at the dose given, such as 
diminished absorption of macronutnents in the gastrointestinal tract 
Until now, little is known about the effects of dietary anticarcinogens on oesophageal, 
gastric and pancreatic GST activity Earlier, Sparnins et al (26,27) showed enhanced 
GST activity in mouse oesophagus and stomach after treatment with coumann and a-an-
gelicalactone In accordance with these results we found that GST activity was significant-
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ly increased in rat oesophagus by flavone, coumann and α-angelicalactone and in rat 
stomach by coumann and α-angelicalactone, whereas in pancreas induction of GST 
activity by α-angelicalactone showed borderline significance (P=0 016) Recently, we 
showed that α-angelicalactone was also a strong inducer of GST enzyme activity in 
proximal, middle and distal small intestine, large intestine and liver (6) Taken together, 
these results suggest that α-angelicalactone is a potent anticarcinogen, which may exert an 
antineoplastic effect by enhancement of the GST detoxification system in most tissues of 
the gastrointestinal tract 
To better understand the modulation of drug-metabolizing enzymes as a possible 
chemoprevention mechanism of dietary anticarcinogens, it may be important not only to 
measure total enzyme activity but also to study eventual changes in GST isozyme levels 
(6,7,15,28) This is the first study where quantitative data on rat oesophageal, gastric and 
pancreatic GST isozyme levels are presented GST-μ is quantitatively the most pro­
nounced expressed isozyme in the organs of the upper gastrointestinal tract of control 
animals investigated here Besides GST-μ, in stomach significant levels of GST class-α 
isozymes are also present, whereas in pancreas class-7r GST is found In all cases where 
induction of GST enzyme activity occurred, a significant increase in one or more classes 
of GST isozymes was also observed Furthermore, there seemed to be a tissue-specific 
preference for induction of particular GST isozymes in oesophagus mainly GST-α levels 
were increased, whereas in stomach GST-π levels were most effected by the anticar­
cinogens GST isozyme levels also changed without significant alteration in overall 
enzyme activity, which was found for GST-μ and GST ж in pancreas after treatment with 
ellagic acid or flavone, respectively 
No data on effects of these anticarcinogens on rat oesophageal, gastric or pancreatic 
GSH levels have been reported before However, Sparnins et al (26,27) showed up to 
1 5 fold induction of acid-soluble sulfhydryl levels in stomach and oesophagus of mice by 
coumann or α-angelicalactone In our study, GSH seems uninfluenced, although levels in 
oesophageal and gastric epithelium of a-angelicalactone fed rats were borderline 
significantly increased (1 3 fold, P = 0 016) 
Using a HPLC method we could not detect GSH in pancreatic tissue of control as well 
as treated rats, this finding is in accordance with the results of Toyo'oka el al (29), also 
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using a specific HPLC method. Other investigators (30-32) claim to find high GSH levels 
in rat pancreatic tissue. However, they all use a colorimetrie method detecting all -SH 
groups instead of only GSH, this may result in overestimation of GSH levels in several 
tissues as shown by Potter et al (33) 
Above data show a pronounced difference in responsiveness to induction between the 
organs (oesophagus > stomach > pancreas). One can speculate this may be the result of 
differences in exposure time and exposure intensity In oesophagus and stomach exposure 
time and exposure intensity to the dietary anticarcinogens may be longer and higher as 
compared to the pancreas, which is not in direct contact with the inducing compounds. 
In conclusion, the dietary naturally occurring anticarcinogens ellagic acid and more 
especially flavone, coumarin and a-angelicalactone may exert strong chemoprotective 
effects in oesophagus or stomach, and to a lesser extent in pancreas by enhancing the 
GST detoxification system. 
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Abstract. 
The naturally occurring anticarcinogens flavone and α-angelicalactone incorporated 
separately and simultaneously in the diet at 0 5, 0 1, 0 05 and 0 01% w/w, were studied 
with respect to their effects on oesophageal, gastric, intestinal, colonic and hepatic (ι) 
glutathione S-transferase (GST) enzyme activity, (u) GST isozyme levels and (in) 
glutathione (GSH) content in male Wistar rats GST enzyme activity was significantly 
increased in the three treatment groups at one or more sites Most substantial inductions 
were seen in oesophagus and stomach by 0 5% α-angelicalactone (1 9- and 2 3-fold, 
respectively), in small intestine, colon and liver by 0 5% combination diet (2 5-, 1 4- and 
4 0-fold, respectively) The inducing capacities declined with decreasing anticarcinogen 
concentrations GST enzyme activity was induced in liver and to a lesser extent in small 
intestine and stomach In general, in combination groups similar effects were seen as after 
treatment with α-angelicalactone or flavone separately However, colonic GST enzyme 
activity was increased in the 0 5% combination group (1 4-fold), whereas in the corre­
sponding flavone or α-angelicalactone groups no induction was observed Concomitant 
changes in GST isozyme levels occurred The involvement was the highest for GST-a 
(75%), followed by GST-μ (58%) and GST-тг (33%) Increased GSH levels were 
obtained in stomach and liver in all three treatment groups at various concentrations 
Above data demonstrate that dietary administration of flavone or a-angelicalactone, even 
at relatively low concentrations, may exert chemopreventive effects in stomach, small 
intestine, liver and to a lesser extent in oesophagus by enhancing the GST detoxification 
system, mainly by induction of GST-α and GST-μ isozymes In addition, simultaneous 
administration of flavone and α-angelicalactone may result in anticarcinogenic effects in 
the colon by the same principle 
Introduction. 
Epidemiological studies have shown the importance of dietary habits in the risk for 
gastrointestinal tumours in general and in colon cancer more particularly Diets rich in 
vegetables and fruit are associated with a lower risk (1,2) In the face of these 
epidemiologic associations many dietary non-nutrient constituents with anticarcinogenic 
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properties have been identified (3-6) Though the exact mechanism(s) leading to the 
anticarcinogenic action of these compounds is not known, it has been suggested that the 
chemoprotective action may be due to elevation of detoxification enzymes (5-8) Impor­
tant drug-metabolizing or detoxification enzymes are glutathione S-transferases (GSTs, 
E C 2 5 1 18), a family of enzymes divided into three main classes α, μ and π Each 
class consists of several isozymes with partly overlapping substrate specificities (9-11) A 
fourth class (Θ, theta) has recently been described in man and rat (12) GSTs catalyze the 
reaction of a wide variety of electrophiles with glutathione (GSH) Since most of the 
chemical carcinogens are electrophiles, GSTs take on considerable importance in car­
cinogen inactivation (13,14) Enhancing the activity of the GST detoxification system 
potentially could increase the capacity to withstand the burden of toxicants and 
(pre)carcinogens we are exposed to daily (5,15,16) Furthermore, even a change in GST 
isozyme profile, without alteration in total enzyme activity, may result in a different risk 
on DNA damage due to the substrate specifity of the various GST isozymes (9-11) In 
several animal studies an enhancement of GST activity was shown after feeding 
anticarcinogens However, in general a very high dose of anticarcinogens was given and 
only in some studies dose-dependency was investigated (17-22) Furthermore, no study 
was performed where combinations of anticarcinogens were given This seems of the 
utmost importance to us since the human diet contains complex mixtures of 
anticarcinogens and these combinations may vary in their effects on GSTs when compared 
to anticarcinogens administered separately Knowledge of the protection mechamsm(s) of 
anticarcinogenic compounds present in food may be important for cancer prevention since 
research could then be focussed on finding the most potent chemopreventive substances 
Recently we tested 10 different anticarcinogens at high dose level for effects on GSTs, 
and flavone and α-angelicalactone were found to be the most potent inducers (7) In order 
to understand better the anticarcinogenic potential of dietary flavone and a-angelicalactone 
we have determined their effects, either given separately or in combination at various 
concentrations, on rat oesophageal, gastric, intestinal, colonic and hepatic (ι) GST enzyme 
activity, (a) GST isozyme levels and (m) GSH content 
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Materials & Methods. 
Treatment of animals Male Wistar rats (243 + 19 g), were obtained from the Central 
Laboratory Animal Centre (University of Nijmegen, The Netherlands) The animals were 
housed individually on wooden shavings in macrolon cages maintained at 20-25 °C and 
30-60% relative humidity A ventilation rate of seven air changes/hr and a 12-hr 
light/dark cycle were used The rats were randomly assigned to one ot the treatment 
groups All groups were fed powdered RMH-TM lab chow (Hope Farms, Woerden, The 
Netherlands) After acclimatization for three days, the animals were fed either the basal 
diet (control group) or one of the twelve experimental diets Ammals were allowed free 
access to food and water, and food cups were replenished with freshly prepared diet every 
2-3 days Food consumption and gain in body weight were recorded daily After two 
weeks the animals were killed by decapitation 
Diets Flavone and a-angelicalactone were incorporated in the diet, either separately or 
as a combination of both compounds, at 0 5, 0 1, 0 05 and 0 01% w/w respectively A 
food processor was used to obtain a homogeneous mixture of test compound(s) and basal 
diet (23) 
Tissue preparation and assays Tissue handling, isolation of epithelium and preparation 
of 150,000 g supernatants (cytosolic fractions) were performed as described previously 
(23) Protein concentration was assayed in duplicate by the method of Lowry et al (24) 
using bovine serum albumin as the standard GST activity with l-chloro-2,4-dimtroben-
zene (CDNB) as substrate was determined according to Habig et al (25) Cytosolic GST 
samples were subjected to sodium dodecyl suliate-polyacrylamide gel electrophoresis 
(11% acrylamide w/v) and subsequently to western blotting (23) The western blots were 
incubated with monoclonal antibodies against human GST class-α (26), -μ (27) and -тг 
(28) Class-α antibodies react with rat GST subunit 1, class-π antibodies with rat GST 
subunit 7 and class-μ antibodies with rat GST subunits 3 and 4 The specific binding of 
the monoclonal antibodies was detected with 4 chloro-1-naphthol after incubation with 
peroxidase-conjugated rabbit anti-mouse immunoglobulins as the second antibody 
(Dakopatts, Glostrup, Denmark) Staining on the immunoblots was quantified using a 
laser densitometer (Ultrascan LKB, Bromma, Sweden) Known amounts of purified GST-
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α, -ж and -μ were run in parallel with the experimental samples and served as standards 
for the calculation of the absolute amounts of these enzymes (23) Total glutathione was 
quantified by high performance liquid chromatography (HPLC) after reaction with 
monobromobimane as described previously (7) 
Materials Flavone, CDNB , bovine serum albumin and GSH were purchased from the 
Sigma Chemical Co (USA) α-Angelicalactone was obtained from Aldrich Chemie 
(Germany), and monobromobimane from Calbiochem Co (USA) Flavone and a-
angelicalactone were of the highest grade purity commercially available (99% and 98%, 
respectively) 
Statistical analysis When the Kruskal-Wallis one-way analysis of variance gave a 
significant F test (P<0 05), the Wilcoxon rank-sum test was used to assess statistical sig­
nificance of differences between experimental and control groups '1P<0 025, b P < 0 010, 
and CP< 0 005 
Results. 
Daily food consumption, total anticarcinogen intake, and daily gain in body weight of 
the rats are given in Table I Although in the 0 5% α-angelicalactone and 0 5% combina­
tion groups food consumption was statistically significantly reduced, total anticarcinogen 
intake was still increased in increments with higher concentrations in the diet At 
termination of the experiment, daily gain in body weight for 0 5% a-angelicalactone, 
0 5% and 0 1% flavone, and 0 5% combination groups was significantly lower as 
compared with the control group In the latter experimental group animals even lost 
weight during the experiment No macroscopical or behavioural signs of toxicity were 
observed in any of the animals 
Table II shows the effects of the various concentrations of dietary a-angelicalactone 
and flavone, given individually or in combination, on GST activity in the five organs 
investigated oesophagus, stomach, small intestine, colon and liver All three treatments 
tested increased GST activity at one or more sites The largest inductions were seen in 
oesophagus and stomach by 0 5% a-angehcalactone (1 9- and 2 3-fold, respectively), in 
small intestine, colon and liver by 0 5% combination (2 5-, 1 4- and 4 0-fold, 
59 
Chapter V 
respectively) The inducing capacity declined with decreasing concentrations However, 
hepatic GST activity was still enhanced by flavone and combination treatments at 
concentrations as low as 0 05% (1 5- and 1 9 fold, respectively) Interestingly, colonic 
GST activity was significantly increased in 0 5% combination group (1 4-fold), whereas 
a-angelicalactone or flavone given individually were not able to induce GST activity In 
oesophagus an opposite effect was observed, GST activity was increased by 0 5% a-
angelicalactone (1 9-fold), whereas flavone and combination treatment did not influence 
GST activity 
Table I Daily food consumption total anticaranogen intake and gain in body weight of male 
Wistar rats receiving diets supplemented with a angelicalactone and flavone individually and in 
combination 
Treatment group % w/w N Food consumption Total anticaranogen Gain in body 
(g/day) intake weight 
(mg/day kg bw) (g/day) 
Control 
a-Angelicalactone 
Flavone 
Combination 
-
0 5 
0 1 
0 05 
0 01 
0 5 
0 1 
0 05 
001 
0 5/0 5 
0 1/0 1 
0 05/0 05 
0 01/0 01 
9 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
19 8 ± 0 4 
154 ± 1 Ie 
19 1 + 0 4 
20 4 ± 0 3 
20 6 + 0 5 
18 1 ± 2 5 
19 1 + 0 4 
22 0 ± 0 7 
20 2 ± 0 3 
8 4 ± 2 0C 
21 5 + 0 6 
21 0 ± 0 5 
20 8 ± 10 
308 
76 
41 
8 
362 
76 
44 
8 
336 
172 
-
± 22 
± 2 
± 1 
± о 
+ 50 
± 2 
± I 
± 0 
± 80 
± 5 
84 ± 2 
16 + 1 
3 2 + 01 
17 + 02° 
2 9 + 0 3 
3 8 + 0 1 
37 ± 0 1 
0 1 ± 0 2C 
26 + 0 l b 
3 1 + 0 3 
3 2 ± 0 2 
3 1 + 0 1L 
3 2 + 0 2 
3 0 + 0 1 
3 0 + 01 
/V = number of animals Values given are means ± SEM The Wilcoxon rank sum test was used 
to assess statistical significance of differences between control and treated groups "P<0 025, 
hP<0 01 and CP<0 005 In the combination group both flavone and a angelicalactone are 
supplemented to the diet m equal amounts 
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Table II. Effects of dietary a-angelicalactone and flavone, individually and in combination, on rat 
hepatic and gastrointestinal GST activity 
Treatment group 
Control 
a-Angelicalactone 
Flavone 
Combination 
% w/w 
: 0 5 
0.1 
0.05 
0 01 
0 5 
0.1 
0 05 
0 01 
0.5/0 5 
0.1/0.1 
0.05/0 05 
0 01/0 01 
Oesophagus 
47 + 4 
90 ± 9e 
60 ± 4 
47 ± 5 
42 ± 4 
5 3 + 7 
5 3 + 6 
46 ± 2 
38 + 3 
50 ± 1 
55 ± 5 
53 + 2 
42 ± 4 
GST activity (nmol/min 
Stomach 
135 + 6 
306 + 16e 
170 + I I a 
152 + 10 
131 + 4 
128 ± 9 
123 ± 2 
132 ± 4 
139 ± 5 
177 + 9b 
166 + 7b 
153 + 9 
133 ± 6 
Small intestine 
525 ± 36 
1272 ± 56e 
756 + 62a 
576 + 17 
499 + 32 
1069 ± 39e 
558 ± 24 
581 + 23 
525 ± 43 
1337 ± 79e 
848 ± 31e 
607 ± 42 
661 + 61 
mg protein) 
: Colon 
87 + 5 
105 ± 8 
96 ± 8 
96 + 8 
89 ± 8 
105 ± 7 
80 + 3 
81 ± 4 
92 ± 8 
119 + 7b 
99 + 9 
90 + 4 
78 ± 6 
Liver 
1705 ± 88 
2867 ± 68e 
2079 + 101a 
1850 ± 80 
1538 ± 122 
6692 ± 391e 
3406 + 176e 
2499 + 94e 
1706 ± 155 
6809 ± 590e 
3982 ± 228e 
3268 ± 87e 
1923 ± 46 
GST activity was determined in triplicate as described in Materials & Methods Values given are 
means + SEM. The Wilcoxon rank-sum test was used to assess statistical significance of 
differences between control and treated groups aP<0 025, hP<0 01 and cΡ < 0.005 
Tables III, IV and V show the effects of various concentrations of dietary a-
angelicalactone and flavone, given individually or in combination, on GST class-α, -μ and 
-π isozyme levels, respectively. In control animals, mean GST-α levels were undetectable 
in oesophagus and colon, low in stomach (197 + 91 ng/mg protein) and relatively high in 
small intestine (5752 + 391 ng/mg protein) and liver (8441 ± 469 ng/mg protein). GST-
a was not influenced in stomach and remained undetectable in colon during treatment. 
Intestinal GST-α levels were induced by 0.5% flavone and 0.5% combination (both 1.8-
fold). Hepatic GST-α levels were elevated by all three treatments at the highest concent­
rations However, combination treatment was able to increase hepatic GST-α levels (1.5-
fold) at concentrations as low as 0.05%, whereas a-angelicalactone or flavone at the 
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same concentration but given separately were not able to elevate GST-α levels. In 
oesophagus GST-α was expressed at low levels after a-angelicalactone (0.5% and 0.1%) 
and combination treatment (0.5%, 0.1% and 0 05%), whereas GST-α was not detectable 
in oesophagus of control or flavone treated animals 
Table 111 Effects of dietary a-angelicalactone and flavone, individually and ¡n combination, on rat 
hepatic and gastrointestinal GST-a levels. 
Treatment group 
Control 
a-Angelicalactone 
Flavone 
Combination 
% w/w 
0 5 
0.1 
0.05 
0.01 
0.5 
0 1 
0 05 
0 01 
0 5/0 5 
0 1/0 1 
0 05/0 05 
0 01/0 01 
Oesophagus 
ND 
214 ± 29c 
63 ± 19a 
ND 
ND 
ND 
ND 
ND 
ND 
114 ± 30c 
127 + 66a 
42 ± llb 
ND 
GST 
Stomach 
197 
429 
288 
65 
69 
182 
162 
52 
108 
± 91 
± 196 
+ 161 
± 41 
± 69 
+ 163 
± 61 
± 34 
+ 58 
59 ± 40 
169 
329 
132 
± 108 
± 88 
± 132 
-a level (ng/mg protein) 
Small intestine 
5752 ± 391 
9681 ± 1160 
7164 ± 760 
7326 ± 1104 
4266 ± 517 
10340 ± 1663a 
5184 + 690 
5896 ± 694 
5820 + 493 
10250 ± 1474e 
6206 + 501 
6467 +1150 
6543 ± 772 
Colon 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
Liver 
8441 + 469 
13712 + 558° 
12435 ± 2355 
10976 ± 1053 
7298 ± 810 
18126 ± 725e 
14182 + 867e 
11927 ± 1996 
11337 ± 1436 
24770 ± 1830e 
15845 + 2869a 
12440 ± 886L 
7147 + 378 
GST-a level was determined as described in Materials & Methods Values given are means ± 
SEM ND = not detectable, detection limit 50 ng/mg The Wilcoxon rank-sum test was used to 
assess statistical significance of differences between control and treated groups- aP<0 025, 
bP<0 010and€P<0 005 
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GST-μ was expressed at high levels in all tissues investigated, but only oesophageal and 
hepatic GST-μ levels were influenced by the dietary anticarcinogens used here, a-
Angelicalactone at the highest concentration increased oesophageal and hepatic GST-μ 
levels 1.5- and 1.4-fold, respectively. In addition, hepatic GST-μ levels were influenced 
by combination treatment at 0.5% (2.1-fold) and 0 1% (1 6-fold), and by flavone at 0 5% 
(2.2-fold), 0.1% (1.8-fold) and 0 05% (1.6-fold). 
Table V Effects of dietary a-angelicalactone and flavone, individually and m combination, on rat 
hepatic and gastrointestinal GST-тг levels 
Treatment group 
Control 
a-Angelicalactone 
Flavone 
Combination 
% w/w 
0 5 
0 1 
0 05 
0 01 
0 5 
0.1 
0 05 
0 01 
0 5/0 5 
0 1/0 1 
0 05/0 05 
0 01/0 01 
Oesophagus 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
GST-* 
i Stomach 
1071 + 161 
4941 + 752c 
1710 + 345 
1365 + 241 
1385 ± 158 
1350 + 233 
977 ± 147 
823 + 133 
1233 ± 283 
2927 ±718° 
1564 ± 174 
1569 + 408 
890 + 168 
level (ng/mg protein) 
Small 
intestine 
264 + 63 
413 + 177 
211 ± 88 
253 ± 104 
260 ± 125 
285 + 99 
106 ± 57 
148 ± 96 
170 ± 71 
421 ± 274 
155 + 64 
368 + 166 
296 ± 117 
Colon 
1003 + 2 1 7 
790 ± 217 
1840 ± 532 
1063 ± 444 
671 ± 169 
1010 ± 257 
520 ± 156 
868 ± 156 
948 ±310 
901 ± 291 
915 + 319 
829 ± 349 
605 ± 199 
Liver 
ND 
ND 
ND 
ND 
ND 
869 ± 85c 
ND 
ND 
ND 
392 ± 59c 
ND 
ND 
ND 
GST-π level was determined as described in Materials & Methods. Values given are means + 
SEM ND = not detectable, detection limit 50 ng/mg The Wilcoxon rank-sum test was used to 
assess statistical significance of differences between control and treated groups "P<0 025, 
bP<0 010andcP<0.005 
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In the control group GST-x was undetectable in oesophagus and liver, low in small 
intestine (264 ± 63 ng/mg protein), and relatively high in stomach (1071 ± 161 ng/mg 
protein) and colon (1003 ± 2 1 7 ng/mg protein). GST-тг was only induced in stomach by 
0 5% α-angelicalactone (4 6-fold) and 0.5% combination (2.7-fold). A remarkable effect 
was seen in liver of 0.5 % flavone and 0.5% combination groups, where GST-π was 
detectable at levels of 869 ± 85 ng/mg protein and 392 ± 59 respectively, whereas GST-
7Γ was undetectable in liver of otherwise treated or control animals. 
In Table VI the data on GSH content are given. GSH levels were increased in stomach 
and liver at various concentrations by all three treatments. 
Table VI Effects of dietary a-angelicalactone and flavone, individually and in combination, on rat 
hepatic and gastrointestinal GSH levels 
GSH (nmol/mg protein) 
Treatment group % w/w Oesophagus Stomach Small Colon Liver 
intestine 
0 5 
0 1 
0 05 
0.01 
0 5 
0 1 
0.05 
0.01 
0.5/0.5 
0 1/0.1 
0 05/0.05 
0 01/0.01 
24 + 2 
35 ± 5 
29 ± 2 
33 + 2 
26 + 2 
26 ± 1 
22 ± 1 
24 ± 3 
23 ± 1 
24 ± 1 
24 ± 4 
29 ± 2 
23 ± 2 
22 + 2 
44 + 2C 
31 + 2b 
32 + 2C 
28 ± l b 
23 + 5 
28 + 2 
26 ± 1 
30 + I e 
29 ± 6 
33 ± 2b 
32 + I e 
30 ± 2a 
10 ± 1 
1 1 + 3 
10 ± 1 
12 ± 2 
9 ± 1 
11 ± 1 
12 + 1 
13 + 1 
8 + 1 
10 + 3 
13 + 2 
12 ± 1 
14 + 3 
26 ± 2 
35 ± 5 
26 + 3 
33 ± 1 
30 ± 1 
25 ± 3 
25 ± 4 
31 ± 1 
27 ± 1 
23 ± 2 
3 1 + 2 
28 ± 3 
27 ± 2 
40 + 2 
50 ± 4 
48 + 2 
44 ± 4 
50 ± 3a 
47 ± 6 
45 ± 3 
56 ± I e 
52 + 5 
34 ± 3 
54 ± 3b 
44 ± 3 
52 ± 11 
GSH level was determined as described in Materials & Methods Values given are means ± SEM 
The Wilcoxon rank-sum test was used to assess statistical significance of differences between 
control and treated groups: aP<0 025, bP<0 010 and CP<0 005 
Control 
a-Angelicalactone 
Flavone 
Combination 
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Discussion. 
It is well accepted that lifestyle factors affect the development of human cancer in 
general, and in particular gastrointestinal tumours (1,2) For instance, the human diet 
contains a large number of well-known (pre)carcinogens that may be of relevance in this 
respect (15,16) However, apart from carcinogens our diet also contains a variety of com­
pounds that inhibit mutagenesis and/or carcinogenesis in laboratory models (16,29-31) 
These anticarcinogens are very diverse in chemical structure, and their protective 
mechanisms are generally unclear However, there are some indications that 
anticarcinogens are effective by virtue of enhancing detoxification systems (3,6-8) These 
detoxification systems, such as GSTs, can reduce carcinogenicity by Phase II conjugation 
reactions, which add functional groups to the carcinogen, thereby lowering biological 
activity and increasing its excretabihty (13 14) Although conjugation with GSH is 
generally recognized as a detoxification pathway, some compounds, such as 1,2 
dibromoelhane and hexachlorobutadiene, are known to be activated (10,11,14) 
In four groups (0 5% α-angelicalactone, 0,5% and 0,1% flavone, 0,5% combination) 
the daily gain in body weight was lower as compared to controls (Table I) For 0 5% α 
angelicalactone and 0 5% combination treatment, the lower gain in body weight can be 
explained by the decreased food consumption In the 0 5% combination group, food 
consumption was strongly diminished (58%) and the rats even lost weight during the 
course of the experiment However Brouard et al (32) showed that a lower gain in body 
weight due to a restricted diet had no influence on the inducibility of drug metabolizing 
enzymes in liver and intestine In the 0 5% and 0 1% flavone groups, despite a normal 
food intake, the daily gain in body weight was lower as compared with controls which 
may be explained by a diminished absorption of macronutnents in the gastrointestinal 
tract as discussed before (8) Flavone or a-angelicalactone given at high concentrations 
(0 3 0 5%) have earlier been reported to influence rodent oesophageal (8,33), gastric 
(8,34), small intestinal (7,33,35), colonic (7) and hepatic (7,19,32,35-37) GST enzyme 
activity in a similar way as observed here Several studies on dose-dependent effects on 
GST by naturally occurring dietary anticarcinogens have been performed (17 22), but data 
on flavone and α-angelicalactone are very limited Siess et al (19) studied effects in the 
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liver by dietary flavone, and found enhanced GST activity after treatment with flavone at 
0 2%, 0 05% and 0 02% (2 6-, 1 5- and 1 2-fold, respectively) In accordance with these 
results, we found that hepatic GST activity was significantly increased by 0 5%, 0 1% 
and 0 05% flavone (3 9-, 2 0- and 1 5-fold, respectively) No induction was obtained at 
0 01%, suggesting that the threshold dose for induction of hepatic GST activity by 
flavone is 0 02% For all other tissues studied here no effects by dietary flavone were 
seen, except for the small intestine at the 0 5% dose With respect to a angehcalactone no 
data on dose-response effects have been reported before GST activity was increased in all 
organs, with the exception of the colon The inducing capacity declined rapidly with 
decreasing concentrations in oesophagus, stomach, small intestine and liver (Table II) and 
the threshold dose for enhancement of gastric, intestinal or hepatic GST activity seems to 
be 0 1 % and for oesophageal GST activity 0 5 % 
Since humans are exposed to mixtures of anticarcinogens in their diet it may be 
worthwhile to study combinations of these compounds in order to reveal possible 
additional effects In general, combination treatment gave similar effects as seen after 
treatment with α-angelicalactone or flavone alone However, colonic GST activity was 
enhanced in the 0 5% combination group (1 4-fold), while in the corresponding flavone or 
α-angelicalactone groups no induction of GST activity occurred 
Modulation of drug metabolizing enzymes, e g GST, as a possible chemopreventive 
mechanism of dietary anticarcinogens may be better understood when in addition to 
measurement of GST enzyme activity also changes in isozyme levels are monitored (7 
11) In 63% of the cases where induction of GST enzyme activity occurred, also a 
significant increase in one or more classes of GST was observed In this group, involve 
ment was highest for GST α (75%), followed by GST μ (58%) and GST-тг (33%) In 
addition, changes in GST isozyme levels without significant alterations in overall enzyme 
activity were found for GST-α in oesophagus by a angehcalactone and combination 
treatment 
GST isozymes show different substrate specificities For instance, the wellknown 
carcinogens aflatoxin Bl and benzo(a)pyrene are detoxified predominantly by class-α and 
class μ GSTs, respectively (13,14) The studies of Francis et al (38) and Sparnins and 
Wattenberg (34) showing flavone and a angehcalactone to be effective against 
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abovementioned carcinogens are in full agreement with the results obtained here 
No data with respect to dose-response effects of α-angel icalactone or flavone on GSH 
levels were reported befoie. In our study, GSH was increased in 42% of the cases where 
GST enzyme activity was induced. The organ with the highest GSH induction incidence 
was the stomach, where a-angelicalactone and combination treatments yielded higher 
GSH values even at the 0.01% dose. Remarkable was the induction of GSH in liver by a 
relatively low dose of all three treatments, whereas no GSH induction was seen at the 
highest dose. 
In conclusion, this study demonstrates that dietary administration of flavone or a-
angelicalactone, even at relatively low concentrations, may exert chemopreventive effects 
by enhancing the GST detoxification system in the stomach, small intestine, liver and to a 
lesser extent in oesophagus mainly by induction of GST-α and -μ isozymes. Furthermore, 
simultaneous administration of flavone and a-angelicalactone may result in 
anticarcinogenic effects in the colon by the same principle. 
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Abstract. 
The effects of consumption of glucosinolate-containing Brussels sprouts on plasma and 
urinary glutathione S-transferase (GST) class-α and -τ were investigated Five male and 
five female non-smoking volunteers were randomly assigned to two groups in a cross­
over design Five persons started on a glucosinolate-free diet (control period), while the 
other five consumed 300 g of cooked Brussels sprouts per day, at the expense of 300 g of 
glucosinolate-free vegetables (sprouts period) Dietary regimes were reversed after one 
week GST levels were measured by enzyme-linked immunoabsorbent assay (ELISA) At 
the end of the sprouts period, a significant increase (1 5-fold) in plasma class-α GST 
levels was observed in males but not in females (control vs sprouts, paired t-test, P-values 
0 031 and 0 317 respectively), while plasma GST class-π levels as well as secretion of 
urinary GST class-α and -тг levels remained unchanged We conclude that (ι) increased 
plasma GST class-α levels in males originate probably solely from the liver and not from 
stomach, intestine or kidney, (a) males are more susceptible for induction of hepatic 
GSTs than females, and (in) urinary GST concentration seems less useful as a biomarker 
for hepatic GST induction 
Introduction. 
Gastrointestinal tumours are among the most common malignancies in Western society 
(1) For this reason, research on prevention of gastrointestinal carcinogenesis is of the 
utmost importance (2) Epidemiological studies show the importance of dietary habits 
Diets rich in cruciferous vegetables, such as Brussels sprouts (Brassica oleraceae), are 
associated with a lower risk (3) The anticarcinogenic properties of cruciferous vegetables 
have been mainly attributed to the degradation products of glucosinolates (4,5) A 
possible mechanism of the chemopreventive action of these constituents may be the induc­
tion of detoxification enzymes (6-9) Important drug-metabolizing or detoxification 
enzymes are glutathione S-transferases (GSTs, E C 2 5 1 18), a family of enzymes with 
tissue-specific distribution For instance, epithelial cells from the small intestine contain 
class-α and -τ isozymes, while in liver only class-α is expressed (10,11) GSTs catalyze 
the reaction of a wide variety of electrophiles to glutathione Since most of the reactive 
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ultimate carcinogenic forms of chemical carcinogens are electrophiles, GSTs contribute 
considerably to carcinogen inactivation (12,13) Enhancement of such detoxifying enzyme 
system potentially could increase the capacity to withstand the burden of toxicants and 
(pre)carcinogens we are exposed to daily (14) Recently Bogaards et al (15) found 
elevated plasma GST class-α levels in males, as a result of consumption of Brussels 
sprouts, and stated that this may represent induced GST class-α levels in liver and other 
gastrointestinal organs, such as the intestine Thus, changes in GST levels in plasma 
could be a useful biomarker for induction of GSTs in several organs including the 
intestine Aims of the present study were (ι) to elucidate the origin of elevated plasma 
GST class-α levels due to dietary intake of glucosinolate-containing Brussels sprouts, (u) 
to reveal possible sex-specific induction of plasma GSTs, and (in) to examine the 
effectiveness of urinary GST levels as biomarker for GST induction by dietary compon­
ents 
Materials & Methods. 
This study was approved by the local Medical Ethical Review Committee and informed 
consent was obtained from the participants prior to the start of the experiment Ten 
healthy non-smoking volunteers (Table 1 ) were randomly assigned to a cross-over 
design Five volunteers (3 females, 2 males) started with a glucosinolate-free diet (control 
period), while the other live (2 témales, 3 males) consumed 300 g of cooked Brussels 
sprouts per day, at the expense of 300 g of glucosinolate-free vegetables (sprouts period) 
After seven days the dietary regimen was changed for another week All standardized 
dinners were prepared and eaten at the Academic Hospital Nijmegen The Brussels 
sprouts used in this study were from the same batch as used previously by Bogaards et al 
(15) Volunteers were asked to refrain from other glucosinolate-containing foods during 
the experiment For their convenience a dietary exclusion list was provided On day 7 of 
both periods (control and sprouts), blood was sampled by venapuncture into EDTA-
containing tubes, and 24-hrs urine samples were collected After centnfugation (2500 χ g, 
10 min), plasma samples were stored at -20°C 
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Table I General data pertaining to the volunteers 
Sex 
female 
male 
female 
male 
female 
male 
female 
male 
female 
male 
Age 
(years) 
27 
22 
23 
24 
23 
26 
22 
26 
29 
21 
Quetelet index 
(kg/m2) 
20 4 
25 2 
21 6 
24 4 
19 3 
25 8 
22 1 
21 5 
194 
19 9 
GST class-α and -тг levels were determined in duplicate using an ELISA All samples 
were determined in the same run Polystyrene 96 wells plates (Gremer BV, Alphen a/d 
Rijn, The Netherlands) were incubated with 100 μΐ of PBS containing mouse anti-human 
GST-a (16) or -τ (17) monoclonal antibody (10 /¿g/ml) al 4°C overnight After removal 
of the free anti-GST-a or -τ antibody the plates were incubated with PBS containing 1 % 
BSA for two hours at room temperature in order to block non-specific binding The plates 
were washed five times with PBS containing 0 05 % Tween 20 (buffer A) and then 
incubated overnight at room temperature with various amounts of purified GST-α and -τ 
(0 2-100 ng/ml in buffer В 20 mM EDTA and 10% heated normal human plasma in 
buffer A) or test plasma (diluted with buffer B) After washing five times, the plates were 
incubated for three hours with rabbit anti-human GST-α or ж antibody, both prepared at 
our laboratory by routine immunization protocol, in PBS containing 1% BSA (diluted 
4,000-fold) The plates were washed again, and incubated for three hours with swine anti-
rabbit IgG antibody conjugated with peroxidase (Dakopatts, Glostrup, Denmark), diluted 
2,000-fold with PBS containing 1% BSA After washing, the peroxidase substrate 
orthophenylenediamine (2 2 mM) in phosphate citrate butter (51 mM Na2HP04, 24 mM 
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citric acid, pH 5 0) containing 0 01% H 2 0 2 was added and the plates were incubated at 
room temperature for 15 minutes Colour reaction was stopped by adding 100 μΐ 4 N 
H2S04 to each well The color intensity of each well was read at 492 nm with a back­
ground subtraction at 620 nm Concentrations were calculated using a nonlinear four-
parameter logistic model The detection limits were 0 05 and 0 2 ng/ml for GST class-α 
and -π respectively Paired t-test or independent t-test were appropriate was used to assess 
statistical significance of differences, P < 0 050 is considered significant 
Results & Discussion. 
Male and female plasma GST class-α and class-7r levels (means ± SEM) as measured 
at the end of both dietary periods are given in Figure 1 GST class-π levels were 
approximately hfteen times higher as compared to GST class-α levels for both males and 
females (P = 0 0025 and Ρ = 0 0005, respectively) Plasma GST class-α levels at the 
end ot the sprouts period were induced 1 5-fold in males but not in females (P-values 
0 031 and 0 317 respectively) Male and female urinary class-α or -τ levels between the 
two periods were uninfluenced (Figure 2 ), although GST class-α and class-π levels in 
males appeared to be increased the change did not acquire statistical significance 
Interestingly, in urine no differences in basal levels between GST class-α and -τ were 
observed Urinary GST class-π levels in females are three times higher as compared to 
those found in males (P = 0 006) This difference could reflect sexe-preferable express­
ion in addition to the already known tissue-specific distribution of GSTs 
In accordance with the results ootained in males after a two-week Brussels sprouts 
dietary regimen by Bogaards et al (15), we also found increased plasma GST class-α 
levels (1 5-fold) in males after consumption of Brussels sprouts for just one week This 
suggests that dietary intervention periods, in order to study GST induction, need not be as 
long as those generally used in human or animal studies Furthermore, consumption of 
glucosmolate containing Brussels sprouts did not alter GST class-α levels in females So 
there seems to be a sex-specific induction of plasma GST class-α levels in humans after 
consumption of glucosinolate-containing Brussels sprouts In rodents, sex-specific or sex-
preferable induction ot GSTs by dietary components has already been reported (18-20) In 
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Fig 1 Effects of consumption of glucosinolate-contaming Brussels sprouts on plasma GST class-
a and -IT levels m females and males Bars represent plasma GST levels (ng/ml, mean ± SEM) 
for both sexes in control period (open bar) and sprouts period (closed bar) as measured by ELISA 
In control period volunteers consumed a glucosinolate-free diet, while in sprouts period volunteers 
consumed 3(X) g of cooked Brussels sprouts per day, at the expense of glucosinolate-free 
vegetables At the end of the sprouts period compared with control period, a significant induction 
(I 5-fold) in plasma GST class-α levels was obsened m males but not infernales {paired t-test, P-
values 0 031 and 0 317, respectively) Plasma GST class-π lexels remained unchanged for males 
and females 
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Fig 2 Effects of consumption of glucosinolate-containing Bruneis sprouts on urinary GST class-a 
and -τ levels in females and males Bars represent urinary GST values (ng/ßmol creatinine, mean 
± SEM) for both sexes in control period (open bar) and sprouts period (closed bar) as measured 
by ELISA In ί ontrol period volunteers consumed a glucosinolate-free diet, while m sprouts period 
volunteers consumed 300 g of cooked Brussels sprouts per day, at the expense of glucosinolate-
free vegetables No statistically significant difference was observed between control and sprouts 
period for either GST class-α or -τ level in both sexes 
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humans class-α GSTs are most abundant in stomach, liver, small intestine and kidney, 
whereas class-7r is present in considerable amounts in stomach, small and large intestine, 
kidney and blood cells (10,11). To elucidate the origin of the elevated plasma GST class-
ex levels in males, we studied plasma GST class-7r levels and urinary GST class-α and 
class-π excretion. No concomitant change in plasma GST class-ir levels was observed in 
males or females. Urinary GST levels seemed not to respond to the dietary 
regimen.Therefore, we conclude that (i) urinary GST levels seems less useful as 
biomarker for gastrointestinal GST induction, and (ii) increased plasma GST class-α 
levels most probably originate from liver and not from stomach, intestine or kidney. In 
addition, no change in liver function parameters (alanine aminotransferase, aspartate 
aminotransferase and gamma-glutamyltransferase) were observed between the two periods 
(data not shown). This strongly suggests that the increased plasma GST class-α levels are 
the result of normal hepatic cell-turnover, with higher GST levels in the liver cell at the 
end of the sprouts period. We hypothesize that this increased hepatic detoxification 
capacity may reflect a lower susceptibility towards toxicants for males, and not for 
females, after consumption of glucosinolate-containing Brussels sprouts. 
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Abstract. 
Background/Aims. A high intake of glucosinolate-containing cruciferous vegetables, such 
as Brussels sprouts (Brassica oleraceae), has been linked to a decreased cancer risk but 
the underlying mechanism is unclear. Aim of this study was to reveal modulating effects 
of consumption of Brussels sprouts on intestinal and lymphocytic glutathione and 
glutathione S-transferases (GSTs). Methods: Ten healthy non-smoking volunteers were 
randomly assigned to two groups in a cross-over design, and consumed a glucosinolate-
free diet (control period) or 300 g of cooked Brussels sprouts per day (sprouts period). 
After seven days the dietary regimen was reversed. At the end of both periods duodenal 
and rectal biopsies, and lymphocytes were evaluated regarding GST activity, isozyme 
levels and glutathione content Results: Mean GST activity, isozyme levels and 
glutathione content showed marked differences between duodenal, rectal and lymphocytic 
cytosols. However, only rectal GST-α and -τ levels were increased at the end of the 
sprouts period by 30% and 15%, respectively. Conclusion: Consumption of Brussels 
sprouts for one week results in increased rectal GST-α and -τ isozyme levels, and these 
enhanced detoxification enzyme levels may partly explain the epidemiological finding that 
a high intake of cruciferous vegetables (glucosinolates) is associated to a lower risk for 
colorectal cancer. 
Introduction. 
Gastrointestinal tumors in general and colorectal cancer in particular are among the 
most common malignancies in Western society Despite recent advances in diagnosis and 
therapy the survival rates are still low (1). For this reason, research on prevention of 
gastrointestinal carcinogenesis is of the utmost importance. Epidemiological studies have 
shown that life-style factors, e.g dietary habits may largely determine each individuals 
tumor risk. Diets rich in cruciferous vegetables, such as Brussels sprouts (Brassica 
oleraceae), are associated with a lower risk (2). The anticarcinogenic properties of 
cruciferous vegetables have been mainly attributed to the degradation products of 
glucosinolates e.g. (iso)thiocyanates and indoles (3). A possible mechanism of action of 
these constituents may be the induction of gastrointestinal detoxification enzymes (4-9) 
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Important drug-metabolizing or detoxification enzymes are glutathione S-transferases 
(GST, E С 2 5 1 18), a family of isozymes divided into three main classes α, τ and μ 
(10-12) Recently a fourth class θ (theta) has been described in human and rat liver (13) 
GSTs catalyze the reaction of a wide variety of electrophiles to glutathione (GSH) Since 
most of the reactive ultimate carcinogenic forms of chemical carcinogens are elec­
trophiles, GSTs may contribute considerably to carcinogen inactivation (12,14) Enhance­
ment of this detoxifying enzyme system potentially could increase the capacity to 
withstand the burden of toxicants and (pre)carcinogens we are exposed to every day, and 
may thus reduce the risk for developing cancer (15,16) 
Aim of the present study was to reveal whether the GST detoxification system in 
humans could be induced by consumption of glucosinolate-contammg Brussels sprouts 
Materials & Methods. 
Outline of the study Ten healthy non-smoking volunteers (5 males and 5 females, 
mean age 24 ± 1 years, Quetelet index, 22 0 + 0 8 kg/m2) were randomly assigned to a 
cross over design experimental protocol Five volunteers (3 females, 2 males) started on a 
glucosinolate-free diet (control period), while the other five consumed 300 g of cooked 
Brussels sprouts per day, at the expense of 300 g of glucosinolate-free vegetables (sprouts 
period) After seven days the dietary regimen was reversed for another week Volunteers 
were asked to keep their habitual diet but to refrain from other glucosinolate-containing 
foods during the experiment For their convenience a dietary exclusion list was provided 
Furthermore, subjects were instructed not to drink more than one alcohol-containing 
consumption per day and to abstain from any medication during the study All standard 
îzed dinners were prepared and consumed at the University Hospital St Radboud The 
Brussels sprouts used in this study were from the same batch as used previously by 
Bogaards et al (17) One kg of Brussels sprouts contained the following glucosinolates 
sinignn 2 15 mmol, glucobrassicin 0 38 mmol, neoglucobrassicin 0 04 mmol, progoitnn 
0 62 mmol and gluconapin 0 19 mmol 
Daily intake of total energy and of the macronutnents fat, protein and carbohydrate 
were calculated from dietary diaries kept for three days in both periods, using the 
1989/1990 release of the Netherlands nutrient data bank At the end of both periods, 
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biopsies were taken by endoscopy (ι) from the descending part of the duodenum, ten 
centimeters from the pylons, and (u) from the rectum, ten centimeters from the anus 
without previous laxation In addition, blood samples were collected by venapuncture into 
EDTA-contaimng tubes Lymphocytes were isolated using Histopaque-1077, according to 
the manufactors instructions (Sigma Diagnostics, St Louis, USA) and plasma samples 
were made by centnfugation at 2500 g for 10 min All material was immediately frozen 
in liquid nitrogen and stored at -80°C For preparation of cytosolic fraction, biopsies 
were quickly thawed using cold running water, homogenized with buffer A (0 25 M 
saccharose, 20 mM Tris, 1 raM dithiothreithol, pH 7 4) using disposable polypropylene 
pestles and microtubes (Kontes, Van Oortmerssen, Rijswijk, The Netherlands) The 
homogenate was centnfuged at 150,000 g (4°C) for 1 hour Lymphocytes were slowly 
thawn and buffer A was added for homogenization as mentioned above The homogenate 
was centnfuged at 12,000 g (4°C) for 30 minutes Ahquots of post centnfugation 
supernatant, representing the cytosolic fraction, were frozen in liquid nitrogen and stored 
(-80°C) until determination 
This study was approved by the local Medical Ethical Review Committee and informed 
consent was obtained from the participants prior to the start of the experiment 
Assays Plasma thiocyanate concentration was determined according to Pettigrew and 
Fell (18) Protein concentration was assayed in triplicate by the method of Lowry et al 
(19) using bovine serum albumin as the standard Total GST enzyme activity with 1-
chloro-2,4-dimtrobenzene (CDNB) as substrate was determined in triplicate according to 
Habig et al (20) Cytosolic samples were subjected to SDS-polyacrylamide gel electro­
phoresis (11% acrylamide, w/v) and western blotting (21) The western blots were 
incubated with monoclonal antibodies against human GST class-α, -μ and -π as described 
previously (21,22) The specific binding of the monoclonal antibodies was detected with 
4-chloro-l-naphthol after incubation with peroxidase-conjugated rabbit anti-mouse 
immunoglobulins as second antibody (Dakopatts, Glostrup, Denmark) Staining on the 
immunoblots was quantified using a laser densitometer (Ultrascan, LKB, Bromma, 
Sweden) Known amounts ot purified GST-α, -μ and π were run m parallel with the 
experimental samples and served as standards for the calculation of the absolute amounts 
of these enzymes (7,21,22) Glutathione was quantified by high performance liquid 
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chromatography (HPLC) after reaction with monobromobimane as described previously 
(7). 
Materials. CDNB, bovine serum albumin, glutathione, were purchased from the Sigma 
Chemical Co. (USA) and monobromobimane from Calbiochem Co. (USA). 
Statistical analysis. All values given are means ± SEM. Wilcoxon matched-pairs 
signed-ranks test was used to assess statistical significance between control and sprouts 
period: aP<0.050, bP<0.025 and CP<0.005. 
Results. 
Total daily intake of energy and of macronutrients, and plasma thiocyanate concentra-
tion in control and sprouts periods are given in Table I. There was no statistical differ-
ence between both periods for total daily caloric intake and for the intake of the 
macronutrients protein, fat and carbohydrate However, the dietary regimen resulted in 
significantly higher (1.8x) plasma thiocyanate concentration in sprouts period as compared 
with control period. 
Table I Effects of dietary regimen on total daily energy intake, macronutnent balance, and 
plasma thiocyanate concentration in healthy non-smoking volunteers 
Period 
Control 
Sprouts 
Total daily 
energy 
(kCal/day) 
2403 + 143 
2409 + 189 
Protein Fat Carbohydrate 
(% total energy) (% total energy) (% total energy) 
1 5 + 1 3 2 + 1 52 ± 1 
16 ± 1 33 ± 1 50 + 2 
SCN" 
(Mg/ml) 
2 98 + 0 34 
5 2 1 + 0.25c 
Daily intake of total energy (kCal/day), protein, fat, and carbohydrate (expressed as percentage of 
total energy intake), and plasma thiocyanate concentration fag SCK/ml plasma) were determined 
as described in Materials & Methods Values given are means + SEM. The Wilcoxon matched-
pairs signed-ranks test was used to assess statistical significance between control and sprouts 
period CP<0 005 
Table II shows duodenal, rectal and lymphocytic GST activities, GST isozyme levels 
and GSH contents at the end of the control period as well as after consumption of 
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Brussels sprouts. Mean total GST activity at the end of the control period showed marked 
differences between duodenal, rectal and lymphocytic cytosols (737 + 54, 321 ± 29 and 
154 + 14 nmol/min mg protein, respectively). Overall GST activity at these sites was not 
influenced by the dietary regimen. Distribution of the isozymes varied greatly between the 
tissues. In duodenum GST-α, -τ and -μ isozymes were expressed in considerable amounts 
(8441 ± 1365, 3002 ± 223 and 536 + 248 ng/mg protein, respectively). Rectal biopsies 
also contained all three GST classes but here GST-7T was the most pronounced isozyme 
(2849 ± 246) and GST-α was only present in minor quantities (149 ± 31). In 
lymphocytes only GST-тг (755 ± 96) and GST-μ (83 ± 54) were detected. As a result of 
the dietary regimen rectal GST-α and -ж levels were slightly increased at the end of the 
sprouts period by 30% and 15%, respectively Duodenal and rectal GSH levels were 
similar and approximately 4-fold higher than found in lymphocytes, but GSH con­
centrations were uninfluenced by the dietary regimen. 
Table II Effects of consumption of glucosinolate-containing Brussels sprouts on duodenal, rectal 
and lymphocytic GST activity, isozyme levels, and GSH concentration m healthy non-smoking 
volunteers 
Parameter 
GST activity (nmol/min mg protein) 
GST-α (ng/mg protein) 
GST-IT (ng/mg protein) 
GST-μ (ng/mg protein) 
GSH (nmol/mg protein) 
Period 
Control 
Sprouts 
Control 
Sprouts 
Control 
Sprouts 
Control 
Sprouts 
Control 
Sprouts 
Duodenum 
737 ± 54 
760 ± 52 
8441 + 1365 
8136 ± 1068 
3002 ± 223 
2889 ± 229 
536 ± 248 
482 ± 177 
46 + 2 
50 + 2 
Rectum 
321 + 2 9 
306 + 24 
149 + 31 
193 + 37b 
2849 ± 246 
3261 + 201a 
495 + 242 
530 + 229 
44 + 1 
42 + 3 
Lymphocyt 
154 ± 14 
165 + 20 
N D 
N D 
755 + 96 
664 ± 59 
83 + 54 
267 ± 156 
11 + 1 
1 3 + 2 
GST activity, GST-a, -τ and -μ levels, and GSH concentration were determined as described in 
Materials & Methods Values given are means ± SEM ND = not detectable, detection limit of 
the assay. 50 ng/mg The Wilcoxon matched-pairs signed-ranks test was used to assess statistical 
significance of differences between control and sprouts periods • aP<0 050 and P<0 025 
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Discussion. 
It is well accepted that dietary habits affect the development of human cancer in 
general and gastrointestinal tumors in particular (2). For instance, high caloric, fat and 
alcohol intake are regarded as risk factors (23). Furthermore, the human diet contains a 
large number of well-known (pre)carcinogens that may be of relevance in this respect 
(15,16,24). However, apart from carcinogens our diet also contains anticarcinogenic 
compounds, e.q minor non-nutritive constituents of vegetables and fruits, which are 
correlated with decreased cancer risk (6,25,26). From animal studies it has been sug-
gested that these compounds may, at least in part, be effective by virtue of enhancing 
detoxification systems (6,7,22,26). These detoxification enzymes, such as GSTs can 
reduce carcinogenicity by conjugation reactions with GSH, which is an efficient biochemi-
cal mechanism that transforms the carcinogen to a compound with lower biological 
activity and increased excretability (12,14). 
Previously, Brussels sprouts have been found to influence hepatic and intestinal GSTs 
in rodents (7,27-32). In humans, evidence for induction of biotransformation enzymes by 
dietary anticarcinogenic compounds is sparse Pantuck et al. (33,34) noticed an increased 
plasma clearance of some drugs after consumption of cruciferous vegetables, indicating 
enhancement of hepatic and/or intestinal biotransformation activity. Hoensch et al. (35) 
measured a decreased monooxygenase activity in small intestine by subjects on a 
semisynthetic diet, which is deficient of vegetable compounds. To our knowledge no data 
on effects of consumption of Brussels sprouts on the gastrointestinal GST detoxification 
system in humans have been reported. 
By exchanging glucosinolate-rich vegetables for glucosinolate-free vegetables in a 
human diet, one could also introduce additional variations, e.g. such as higher or lower 
caloric intake or a shift in macronutrient balance, which could have a significant impact 
on carcinogenesis or biotransformation. However, in our study caloric intake and 
macronutrient balance in both periods were identical and only plasma thiocyanate 
concentration (a biological marker for glucosinolate exposure) was increased at the end of 
the sprouts period. Therefore, to our opinion the observed effects on GSTs are most 
likely the result of differences in glucosinolate exposure. 
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Although overall GST enzyme activity did not change after consumption of Brussels 
sprouts, a small but statistically significant increase in GST-α and -τ levels was observed 
in rectal biopsies In rats similar changes in GST isozyme levels without significant 
alteration in overall enzyme activity after feeding naturally occurring dietary 
anticarcinogens have been reported (7,21) 
Recently, we found an inverse relationship between GST enzyme activity and tumor 
incidence for the organs of the human gastrointestinal tract (36) Tissues with high GST 
activity such as liver and small intestine had a low tumor incidence and vice versa A 
similar relationship seems to exist for GST-α content tissues with high GST-α content 
(liver, small intestine) have a low tumor risk whereas tissues with a low GST-α content 
(colon/rectum, breast, lung) have a high tumor risk In this respect we hypothesize that 
the relatively modest elevation in rectal GST-α level, in addition to the induction of GST-
7Γ, may be of great biological importance refenng to the very low basal GST-α levels 
found in rectum 
Tissue sampling in chemopreventive studies by endoscopy is invasive, time consuming, 
costly and not without any risk Therefore, more convenient sampling procedures with 
lower risk for complications such as venous puncture, would be more favourable for 
evaluating response to dietary anticarcinogens Recently, Bogaards et al (17) reported 
elevated plasma GST-α levels in healthy human volunteers on a Brussels sprouts diet, 
results which are in full agreement with our data (Nijhoff et al , unpublished results) It 
was hypothesized that these elevated plasma levels may be used as a biomarker since they 
reflect normal cell-turnover after selective induction of GST-α in tissues such as liver and 
intestine However, our data indicate that both GST-α and GST-π were induced in 
rectum, whereas only changes in plasma GST-α levels were found From earlier studies, 
it is known that normal human liver contains GST-α in very large quantities and only 
traces of GST-тг (37,38) Therefore, it seems most reasonable to assume that elevated 
plasma GST-α levels without concomitant changes in GST-7T levels reflect effects on 
hepatic and not on intestinal GSTs 
Szarka et al (39) found a significant correlation between GST enzyme activity in lym­
phocytes and colorectal tissue in controls (Spearman's Rank correlation coefficient = 
0 81, P < 0 00001) They suggested that lymphocytic GST activity could be used in future 
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chemopreventive trials to monitor colorectal responsiveness to anticarcinogenic regimens. 
In our study, lymphocytic and rectal GST activities are significantly correlated only in the 
control but not in the sprouts period (r
s
 = 0.78, Ρ = 0.008 and r
s
 = 0.56, Ρ = 0.090, 
respectively). Therefore, to our opinion plasma GST levels and lymphocytic GST 
activities seems less useful as biomarkers for effects of anticarcinogens on intestinal GST 
activities, and tissue samples are still needed in these kind of chemoprevention studies. 
In conclusion, our data demonstrate that consumption of glucosinolate-containing 
Brussels sprouts for one week results in increased rectal GST-α and -π isozyme levels. 
We hypothesize that these induced detoxification enzyme levels may, at least in part, 
explain the epidemiological association between high intake of cruciferous vegetables 
(glucosinolates) and decreased risk for colorectal cancer. 
References. 
1 Coebergh JWW and Van der Heijden LH Cancer incidence and survival 1975-1987, ISBN 
90-5001-005-9, IKZ, The Netherlands, 1990. 
2. Steinmetz KA and Potter JD Vegetables, fruit and cancer. I Epidemiology Cancer Causes 
and Control 1991, 2. 325-357 
3 McDanell R, McLean AEM, Hanley AB, Heaney RK and Fenwick GR. Chemical and 
biological properties of indole glucosinolates (glucobrassicins): a review Food. Chem. 
Toxicol. 1988, 26· 59-70 
4. Bradfield CA and Bjeldanes LF. Modification of carcinogen metabolism by indolylic 
autolysis products of Brassica oleraceae In Friedman M, ed. Nutritional and toxicological 
consequences of food processing New York Plenum Press, New York, 1991: 153-163. 
5. Zhang Y and Talalay Ρ Anticarcinogenic activities of organic isothiocyanates. chemistry and 
mechanisms Cancer Res 1994, 54 1976-1981 
6 Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents Cancer Res 
1992, 52 2085-2091 
7 Nijhoff WA, Groen GM and Peters WHM Induction of rat hepatic and intestinal glutathione 
S-transferases and glutathione by dietary naturally occurring anticarcinogens Int J Oncol 
1993, 3 1131-1139 
8 Morse MA and Stoner GD Cancer chemoprevention principles and prospects 
Carcinogenesis 1993, 14 , 1737-1746 
9 Rogers AE, Zeisel SH and Groopman J Diet and carcinogenesis Carcinogenesis 1993, 14: 
2205-2217 
10 Vos RME and Van Bladeren PJ Glutathione S-transferases in relation to their role in the 
biotransformation of xenobiotics Chem Biol. Interact 1990,75 241-265 
89 
Chapter VII 
11 Mannervik В The isozymes of glutathione transferase In Meister A, ed Adv Enzymol 
1985, 57 357-406 
12 Ketterer B, Meyer DJ, Coles B, Taylor JB and Pemble S Glutathione transferases and 
carcinogenesis In Shankel DM, Hartman PE, Kada Τ and Hollaender A, eds 
Antimutagenesis and anticarcinogenesis mechanisms New York Plenum Press, 1986 103-
126 
13 Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM and Ketterer В Thêta, a new class 
of GSH transferases purified from rat and man Biochem J 1991,274 409-414 
14 Coles В and Ketterer В The role of glutathione and glutathione S-transferases in chemical 
carcinogenesis Crit Rev Biochem Mol Biol 1990, 25 47-70 
15 Ames BN Dietary carcinogens and anticarcinogens Science 1983, 221 1256-1264 
16 Carr BI Chemical carcinogens and inhibitors of carcinogenesis in the human diet Cancer 
1985, 55 218-224 
17 Bogaards JJP, Verhagen H, Willems MI, Van Poppet G and Van Bladeren PJ Consumption 
of Brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood 
plasma Carcinogenesis 1994, 15 1073-1075 
18 Pettigrew AR and Fell GS Simplified colorimetrie determination of thiocyanate in biological 
fluids, and its application to investigation of the toxic amblyopias Clin Chem 1972, 18 
996-1001 
19 Lowry OH, Rosebrough NJ, Farr AL and Randal RJ Protein measurement with the Fohn 
phenol reagent J Biol Chem 1951, 193 265-275 
20 Habig WH, Pabst MJ and Jakoby WB Glutathione S-transferases The first enzymatic step in 
mercaptunc acid formation J Biol Chem 1974, 249 7130-7139 
21 Nijhoff WA and Peters WHM Induction of rat hepatic and intestinal glutathione S-
transferases by dietary butylated hydroxyanisole Biochem Pharmacol 1992,44 596-600 
22 Nijhoff WA and Peters WHM Quantification of induction of rat oesophageal, gastric and 
pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens 
Carcinogenesis 1994, 15 1769-1772 
23 Miller AB, Berrino F, Hill M, Pietinen P, Riboh E and Wahrendorf J Diet in the aetiology 
of cancer a review Eur J Cancer 1994,30 207-220 
24 Davis DL Natural anticarcinogens, carcinogens, and changing patterns in cancer some 
speculation Environmental Res 1989, 50 322-340 
25 Steinmetz KA and Potter JD Vegetables, fruit and cancer II Mechanisms Cancer Causes 
Control 1991, 2 427-442 
26 Wattenberg LW Chemoprevention of cancer Cancer Res 1985,45 1-8 
27 Bradfield CA and Bjeldanes LF Effect of dietary indole-3-carbinol on intestinal and hepatic 
monooxygenase, glutathione S-transferase and epoxide hydrolase activities in the rat Food 
Chem Toxicol 1984, 22 977-082 
90 
submitted. 
28 Bradfield CA, Chang Y and Bjeldanes LF Effects of commonly consumed vegetables on 
hepatic xenobiotic-metabolizing enzymes in the mouse Food Chem Toxicol 1985, 23 899-
904 
29 Salbe AD and Bjeldanes LF The effects of dietary Brussels sprouts and Schizandra 
Chinensis on the xenobiotic-metabolizing enzymes of the rat small intestine Food Chem 
Toxicol 1985, 23 57-65 
30 Hendnch S and Bjeldanes LF Effects of dietary Schizandra Chinenesis, Brussels sprouts and 
Illicium Verum extracts on carcinogen metabolism systems in mouse liver Food Chem 
Toxicol 1986, 24 903-912 
31 Bogaards JJP, Van Ommen В, Falke HE, Willems MI and Van Bladeren PJ Glutathione S-
transferase subumt induction patterns of Brussels sprouts, allyl isothiocyanate and goitnn in 
rat liver and small intestinal mucosa a new approach for the identification of inducing 
xenobiotics Food Chem Toxicol 1990, 28 81-88 
32 Wortelboer HM, De Kruif CA, Van Iersel AAJ, Noordhoek J, Blaauboer BJ, Van Bladeren 
PJ and Falke HE Effects of Brussels sprouts on cytochrome Ρ 450 profile and phase II 
enzymes in liver and small intestinal mucosa of the rat Food Chem Toxicol 1992, 30 17-
27 
33 Pantuck EJ, Pantuck CB, Garland WA, Min BH, Wattenberg LW, Anderson KE, Kappas A 
and Conney AH Stimulatory effect of Brussels sprouts and cabbage on human drug 
metabolism Clin Pharmacol Ther 1979, 25 88-95 
34 Pantuck EJ, Pantuck CB, Anderson KE, Wattenberg LW, Conney AH and Kappas A Effect 
of Brussels sprouts and cabbage on drug conjugation Clin Pharmacol Ther 1984, 35 161-
169 
35 Hoensch HP, Steinhardt HJ, Weiss G, Haug D, Maier A and Malchow Η Effects of 
semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small 
intestinal mucosa in humans Gastroenterology 1984, 86 1519 1530 
36 Peters WHM, Roelofs HMJ, Hectors MPC, Nagengast FM and Jansen JBMJ Glutathione 
and glutathione S-transferases in Barrett's epithelium Br J Cancer 1993, 67 1413-1417 
37 Van Ommen В, Bogaards JJP, Peters WHM, Blaauboer В and Van Bladeren PJ 
Quantification of human hepatic glutathione S-transferases Biochem J 1990,269 609-613 
38 Mulder TPJ, Roelofs HMJ, Peters WHM, Wagenmans MJM, Sier CFM, and Verspaget 
HW Glutathione S-transferases in liver metastases of colorectal cancer A comparison with 
normal liver and primary carcinomas Carcinogenesis 1994, 15 2149-2153 
39 Szarka CE, Pfeiffer GR, Frucht H, Goosenberg EB, Litwin S, Engstrom PF and Clapper 
ML Glutathione S-transferase activity of blood lymphocytes as a marker of human colon 
glutathione S transferase activity Cancer Res 1994, 35 633 
91 
92 
Summary and conclusions. 
Chapter VIII 
Summary and conclusions. 
93 
Chapter Vili 
Summary and conclusions. 
Epidemiological data consistently provide strong evidence that consumption of higher 
levels of vegetables and fruits is associated with reduced cancer risk A large number of 
potentially anticarcinogenic constituents of vegetables and fruits have been identified The 
exact mode of action is still unclear but there are indications that anticarcinogens may be 
effective by virtue of modulating detoxification enzymes, ι e glutathione S-transferases 
(GSTs) GSTs constitute a family of isozymes that collectively metabolize a broad 
spectrum of toxic substances including many (pre)carcinogens Furthermore, a change in 
GST isozyme profile, even without alteration in overall enzyme activity, may result in 
different cancer risk due to substrate specificity of the isozymes In theory, induction of 
GSTs will increase the capacity to withstand the burden of toxicants we are exposed to 
daily and thus will lower the risk for DNA damage 
The aim of the investigations presented in this thesis was to study the relationship 
between dietary anticarcinogens and gastrointestinal GST enzyme activity and isozyme 
composition 
Chapter II reveals the induction of GSTs in rat liver and intestine by dietary butylated 
hydroxyanisole (BHA), a widely used food preservative with anticarcinogenic properties, 
as a possible anticarcinogenic mechanism Quantification of GSTs by densitometrical 
analysis of GST isozyme levels on western blots after immunodetection with monoclonal 
antibodies is introduced 
Chapter HI reports on the effects of a variety of naturally occurring dietary 
anticarcinogens on rat hepatic and intestinal GST detoxification system Most 
anticarcinogens studied, in particular flavone, coumann and a-angelicalactone, enhance 
GST activity in liver and intestine, mainly by induction of class-α and -μ GSTs 
In chapter Г it is shown that flavone, coumann and α-angelicalactone in addition to 
abovementioned tissues also GST isozymes induce in rat oesophagus and stomach 
In order to understand better the anticarcinogenic potential of dietary flavone and a-
angehcalactone we have conducted a dose-response/combination study with these two 
compounds in rats as reported in chapter V Dietary administration of flavone or a-
angehcalactone, even at relatively low concentrations, may exert anticarcinogenic effects 
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in stomach, small intestine, liver and to a lesser extent in oesophagus by enhancing the 
GST detoxification system, mainly by induction of GST-α and -μ isozymes In addition, 
simultaneous administration of flavone and α-angelicalactone may result in chemopreven-
live effects in the colon by the same principle 
Chapter VI describes a cross-over study concerning the effects of consumption of 
glucosinolate-containing Brussels sprouts on plasma and urinary GST class-α and -ж 
concentrations in humans The experimental diet resulted in elevated plasma GST-α levels 
in males which most probably reflect hepatic induction Urinary isozyme concentration 
seems less useful as biomarker for hepatic GST induction 
In chapter VII we report on the effects of consumption of glucosinolate-containing 
Brussels sprouts on intestinal and lymphocytic GSTs in humans The data demonstrate 
that consumption of glucosinolate-containing Brussels sprouts for one week result in a 
small but statistically significant increase in rectal GST-α and -ir isozyme levels It was 
hypothesized that these induced detoxification enzyme levels may partly explain the 
epidemiological association between high intake of glucosinolates (cruciferous vegetables) 
and decreased risk for colorectal cancer 
In summary, we have demonstrated that dietary anticarcinogens have pronounced 
inducing effects on gastrointestinal GST activity and isozyme levels (a > μ > τ) This 
enhanced detoxification capacity may, at least in part, explain the epidemiologic associ­
ation between high intake of vegetables and fruits (anticarcinogens) and a reduced cancer 
risk in general and for gastrointestinal tumours in particular These studies support the 
endeavour to change the current dietary pattern in order to decrease the incidence of 
major health problems such as cancer 
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Samenvatting en conclusies. 
Epidemiologische data geeft consequent sterke bewijzen dat consumptie van grotere 
hoeveelheden groenten en fruit gepaard gaat met een verlaagd risico op het krijgen van 
kanker Een groot aantal van in potentie anticarcmogene bestanddelen van groenten en 
fruit zijn geïdentificeerd Het exacte werkingsmechanisme is nog steeds onduidelijk maar 
er zijn aanwijzingen dat anticarcinogenen mogelijk werkzaam zijn door middel van 
modulatie van detoxificerende enzymen, met name de glutathion-S-transferases (GSTs) 
GSTs bestaan uit een familie van isozymen die gezamenlijk een breed spectrum van 
toxische verbindingen, inclusief een groot aantal (pre)carcinogenen, metabohseren 
Daarnaast kan een verandering in GST isozym profiel, zelfs zonder een verandering in 
totale enzym activiteit, resulteren in een ander kanker risico tengevolge van de substraat 
specificiteit van de isozymen In theorie verhoogt inductie van GSTs de beschermingsca-
paciteit tegen de toxische verbindingen waaraan we dagelijks zijn blootgesteld en hierdoor 
zal de kans op DNA schade afnemen 
Het doel van de onderzoeken beschreven in dit proefschrift was het bestuderen van de 
relatie tussen anticarcinogenen in de voeding en gastrointestinale GST enzym activiteit en 
isozym compositie 
Hoodstuk II onthult inductie van GSTs in lever en darm van de rat door butyl-
hydroxyanisol (BHA), een wijdverbreid conserveringsmiddel met anticarcmogene 
eigenschappen, als een mogelijk werkingsmechanisme Kwantificering van GSTs door 
middel van densitometnsche analyse van GST isozymen op western blots na ïmmuno-
detectie met monoclonale antilichamen wordt geïntroduceerd 
Hoofdstuk III beschrijft de effecten van een scala van natuurlijk voorkomende anticar-
cinogenen in de voeding op het GST detoxificatie systeem in de lever en darm van de rat 
De meeste bestudeerde anticarcinogenen, met name flavon, coumanne en a-angelicalac-
ton, verhogen GST activiteit in lever en darm, voornamelijk door inductie van klasse-α en 
-μ GSTs 
In hoofdstuk IV is aangetoond dat flavon, coumanne en α-angelicalacton naast in de 
bovengenoemde weefsels ook GST isozymen induceren in de slokdarm en maag van de 
rat 
Om de anticarcmogene potentie van flavon en α-angelicalacton in de voeding beter te 
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begrijpen hebben we een dosis-response/combinatie studie met deze twee verbindingen bij 
ratten uitgevoerd zoals beschreven m hoofdstuk V Toediening via het voedsel van flavon 
of α-angelicalacton, zelfs bij relatief lage concentraties, kan anticarcinogene effecten 
teweegbrengen in de maag, dunne darm, lever en in mindere mate in de slokdarm door 
stimulatie van het GST detoxificatie systeem, voornamelijk door inductie van GST-α en -
μ isozymen Tevens kan gelijktijdige toediening van flavon en a-angelicalacton resulteren 
in chemopreventieve effecten in de dikke darm volgens hetzelfde principe 
Hoofstuk VI beschrijft een cross-over studie met betrekking tot de effecten van 
consumptie van glucosinolaat-bevattende spruitjes op klasse-α en -π GST concentraties in 
plasma en urine bij mensen Het experimentele dieet resulteerde in verhoogde plasma 
GST-α niveau's bij mannen, wat waarschijnlijk een afspiegeling is van GST inductie in de 
lever Isozymconcentratie in urine lijkt minder bruikbaar als biomarker voor lever GST 
inductie 
In hoofdstuk VII rapporteren we effecten van consumptie van glucosinolaat-bevattende 
spruitjes op darm en lymfocytaire GSTs bij mensen De data laten zien dat consumptie 
van glucosinolaat bevattende spruitjes gedurende een week resulteert in een kleine maar 
statistisch significante toename van rectale GST-α en -τ isozym niveau's Het werd 
verondersteld dat deze geiduceerde detoxificatie enzym niveau's mogelijk gedeeltelijk de 
epidemiologische associatie tussen hoge opname van glucosinolaten (crucifère groenten) 
en verlaagd risico op colorectale kanker kan verklaren 
Samenvattend, we hebben aangetoond dat anticarcinogenen in de voeding aanzienlijke 
inducerende effecten op gastrointestinale GST activiteit en isozym niveau's (α > μ > τ) 
hebben Deze toegenomen detoxificatie capaciteit kan, minstens gedeeltelijk, de epidemio­
logische associatie tussen hoge consumptie van groenten en fruit (anticarcinogenen) en een 
verlaagd kanker risico in het algemeen en voor gastrointestinale tumoren in het bijzonder 
verklaren Deze studies ondersteunen het streven naar veranderingen in het huidige 
voedingspatroon om de omvang van grote gezondheidsproblemen zoals kanker te 
verkleinen 
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Stellingen 
1. Promoveren is gewoon werken. 
2. De inleiding van het proefschrift hoort aan het einde. 
3. Stellingen over eigen onderzoek verkleinen de kans dat het proef-
schrift gelezen wordt. 
4. De snelheid waarmee onderwerpen in de politieke agenda worden 
op- en afgevoerd rechtvaardigt de vraag of er ook wat wordt 
uitgevoerd. 
5. Het enige artikel dat in geen enkel rik-, tour- of wk-reglement mag 
ontbreken is dat bij discussie de Commissie beslist. 
6. Everyday I have the blues. 
B.B. King I P. Chaman, 1955 
7. Videogames prikkelen de fantasie en verhogen de morele waarden. 
Stellingen behorende bij het proefschrift "Modulation of glutathione S-transferases by 
dietary anticarcinogens", W.A. Nijhoff, 8 mei 1995. 



